Retrieve available abstracts of 415 articles: HTML format
Single Articles
July 2025
YANG L, Li Y, Zeng T, Long M, et al Gene mutation in cancer patients with diabetes: a real-world retrospective cohort
study.
BMC Cancer. 2025;25:1163. PubMedAbstract available
DAI F, Mao C, Guo G, Mei L, et al Predicting exploratory thoracotomy in non-small cell lung cancer: a computed
tomography based nomogram approach.
BMC Cancer. 2025;25:1161. PubMedAbstract available
SHUAI Y, Liu J, Yang Y, Huang X, et al Neoadjuvant immunochemotherapy versus chemotherapy for elderly patients with
IB-IIIB non-small-cell lung cancer in real-world practice.
BMC Cancer. 2025;25:1150. PubMedAbstract available
NIU Y, Jia HB, Li XM, Huang WJ, et al Deep learning radiomics and mediastinal adipose tissue-based nomogram for
preoperative prediction of postoperative? brain metastasis risk in non-small cell
lung cancer.
BMC Cancer. 2025;25:1133. PubMedAbstract available
WANG XC, Xu XL, Wang SY, Cheng H, et al Nomogram based on the advanced lung cancer inflammation index and other relevant
clinical factors for patients with cervical squamous cell carcinoma undergoing
concurrent chemoradiotherapy.
BMC Cancer. 2025;25:1043. PubMedAbstract available
GUO LW, Lyu ZY, Liu Y, Meng QC, et al The probability of lung cancer in patients with pulmonary nodules detected via
low-dose computed tomography screening in China.
BMC Cancer. 2025;25:1058. PubMedAbstract available
LONG L, Jiang L, Teng Y, Yang D, et al Immunotherapy concurrently administered with chemoradiotherapy in limited-stage
small-cell lung cancer.
BMC Cancer. 2025;25:1077. PubMedAbstract available
ZHAO L, Xiong Q, Long Y, Hu H, et al Efficacy and safety of first-line chemoimmunotherapy in young patients with
extensive-stage small cell lung cancer: a multicenter retrospective study.
BMC Cancer. 2025;25:1136. PubMedAbstract available
LIU M, Yang F, Tang B, Xin X, et al Steps towards overcoming challenges in clinical practice at 1.5T MR-Linac for
lung cancer adaptive radiotherapy.
BMC Cancer. 2025;25:1034. PubMedAbstract available
ZHANG J, Wu Z, Wang S, Sun Y, et al Efficacy of PD-(L)1 inhibitors plus anlotinib in the second-line treatment of
extensive-stage small cell lung cancer.
BMC Cancer. 2025;25:1070. PubMedAbstract available
FAIZI MK, Qiang Y, Wei Y, Qiao Y, et al Deep learning-based lung cancer classification of CT images.
BMC Cancer. 2025;25:1056. PubMedAbstract available
June 2025
CHEN H, Yu Y, Zhu S, Zhao J, et al Correction: Impact of metabolic and nutritional disorders on the synergy between
radiotherapy and immunotherapy in non-small-cell lung cancer.
BMC Cancer. 2025;25:1019. PubMed
WANG Y, Su X, Jia J, Zhou T, et al Early radiotherapy improved survival of patients with extensive-stage small cell
lung cancer treated with first-line chemo-immunotherapy.
BMC Cancer. 2025;25:1012. PubMedAbstract available
TONG X, Zhu T, Ma L, Yang X, et al Cathepsin C correlates with M2 macrophage infiltration and regulates the tumor
growth and metastasis in non-small cell lung cancer.
BMC Cancer. 2025;25:1001. PubMedAbstract available
SAEED R, McSorley S, Cascales A, McMillan DC, et al The prognostic/ predictive value of the systematic inflammatory response in
patients receiving immunotherapy for non-small cell lung cancer: a systematic
review and meta-analysis.
BMC Cancer. 2025;25:994. PubMedAbstract available
LI H, Lu Y, Chen H, Li T, et al Identification and validation of a DNA methylation-block prognostic model in
non-small cell lung cancer patients.
BMC Cancer. 2025;25:999. PubMedAbstract available
WASILEWSKI D, Shaked Z, Fuchs A, Roohani S, et al Re-resection of brain metastases - outcomes of an institutional cohort study and
literature review.
BMC Cancer. 2025;25:973. PubMedAbstract available
May 2025
RENAUD S, Casabianca P, Diez-Andreu P, Chartier M, et al Epidemiology, patient management, and survival outcomes in resected patients with
non-metastatic non-small cell lung cancer: a nationwide real-world study.
BMC Cancer. 2025;25:966. PubMedAbstract available
XING H, Wu C, Yang W, Cai S, et al Tracheal, bronchus, and lung cancer among older adults: thirty-year global burden
trends, precision medicine breakthroughs, and lingering barriers.
BMC Cancer. 2025;25:954. PubMedAbstract available
MENG H, Ding RQ, Jia L, Chen XP, et al Photodynamic therapeutic activity of novel porphyrins against lung squamous cell
carcinoma.
BMC Cancer. 2025;25:960. PubMedAbstract available
CHEN H, Yu Y, Zhu S, Zhao J, et al Impact of metabolic and nutritional disorders on the synergy between radiotherapy
and immunotherapy in non-small-cell lung cancer.
BMC Cancer. 2025;25:948. PubMedAbstract available
TAN M, Li L, Tan B, Yang J, et al Innovations in modern low-LET radiotherapy regimens for locally advanced
non-small cell lung cancer: a meta-analysis and systematic review of
high-dose-rate brachytherapy, stereotactic body radiotherapy, and
hypofractionated proton therapy.
BMC Cancer. 2025;25:942. PubMedAbstract available
WU S, Qiu Z, Shi H, Yu W, et al High-dose third-generation EGFR-TKIs combined with intrathecal pemetrexed in
advanced EGFR-mutant NSCLC with leptomeningeal metastases following EGFR-TKI
therapy.
BMC Cancer. 2025;25:926. PubMedAbstract available
HONG M, Yun I, Moon JY Impact of doctor-shopping behavior on patient survival in lung cancer: findings
from a 11-year cohort study using Korean claims data.
BMC Cancer. 2025;25:914. PubMedAbstract available
YANG S, Liu Y, Zhao J, He Z, et al EGFR exon 20 insertions mutation in lung adenocarcinoma and its response by
high-dose of Furmonertinib: a real-world study.
BMC Cancer. 2025;25:900. PubMedAbstract available
ZHENG C, Miao J, Xu L, Cai Y, et al Novel PET imaging biomarkers as predictors of postoperative recurrence in lung
adenocarcinoma.
BMC Cancer. 2025;25:874. PubMedAbstract available
CHEN X, Wang K, Liao Y, Zheng C, et al Safety and efficacy of rechallenge with immune checkpoint inhibitors and
anlotinib in advanced non-small cell lung cancer without targetable driver
mutations: a retrospective analysis.
BMC Cancer. 2025;25:862. PubMedAbstract available
YAO J, Geng Y, Xu J, Zou B, et al The impact of EGFR mutation and PD-L1 status on the efficacy of postoperative
radiotherapy in stage III-pN2 NSCLC.
BMC Cancer. 2025;25:858. PubMedAbstract available
ZHAO S, Du X, Zhang Y, Bai J, et al Development and application of a whole transcriptome sequencing assay for the
detection of gene fusions in clinical cancer specimens.
BMC Cancer. 2025;25:842. PubMedAbstract available
ZHANG J, Zhang Z, Liu Y, Hou Y, et al Metabolic characteristics of benign and malignant pulmonary nodules and
establishment of invasive lung adenocarcinoma model by high-resolution mass
spectrometry.
BMC Cancer. 2025;25:844. PubMedAbstract available
ZHAO F, Bai H, Liu Y, Gao S, et al FLT3LG modulates the infiltration of immune cells and enhances the efficacy of
anti-PD-1 therapy in lung adenocarcinoma.
BMC Cancer. 2025;25:831. PubMedAbstract available
DONG J, Qi Y, Sha S, Fu C, et al Whole-body CT scanning radiation improves the immune microenvironment of tumor
tissues to enhance the antitumor effect of ICI.
BMC Cancer. 2025;25:824. PubMedAbstract available
HAJIKARIMLOO B, Mohammadzadeh I, Tos SM, Habibi MA, et al Machine learning in prediction of epidermal growth factor receptor status in
non-small cell lung cancer brain metastases: a systematic review and
meta-analysis.
BMC Cancer. 2025;25:818. PubMedAbstract available
April 2025
KUANG S, Xiao S, Zhou J, Liu L, et al Combined effect of areca nut, cigarettes, alcohol and SNPs in glycosyltransferase
family genes on lung cancer development in Hainan, China.
BMC Cancer. 2025;25:814. PubMedAbstract available
LIAO J, Hu X, Wei X, Dai W, et al Sex-related differences in postoperative patient-reported outcomes among lung
cancer patients: a multicenter cohort study.
BMC Cancer. 2025;25:800. PubMedAbstract available
ZHU Q, Hu H, OuYang LY, Yang R, et al The association of PD-L1 expression status and the PD-1/PD-L1 inhibitor-related
toxicity profile in non-small cell lung cancer.
BMC Cancer. 2025;25:799. PubMedAbstract available
WANG Y, Ma X, Ma J, Li J, et al Thyroid dysfunction as a predictor of PD- 1/PD-L1 inhibitor efficacy in advanced
lung cancer.
BMC Cancer. 2025;25:791. PubMedAbstract available
OU G, Gao T, Hu S, Zhang S, et al Comprehensive pan-cancer analysis of CHRDL1 and experimental validation of its
role in lung adenocarcinoma.
BMC Cancer. 2025;25:783. PubMedAbstract available
LI S, Huang Z, Zhong X, Zhou Y, et al The real-world safety profile of pemetrexed and platinum with or without
pembrolizumab: insights from a comparative analysis of FAERS database.
BMC Cancer. 2025;25:767. PubMedAbstract available
MINE H, Sugimoto K, Kobayashi M, Takagi H, et al Abnormal phosphorylation of human LRH1 at Ser510 predicts poor prognosis and
promotes cell viability in lung squamous cell carcinoma.
BMC Cancer. 2025;25:764. PubMedAbstract available
DAI L, Huang L, Li L, Tang L, et al Pretreatment plasma sCD14 as a prognostic indicator in advanced non-small cell
lung cancer patients undergoing immunotherapy.
BMC Cancer. 2025;25:763. PubMedAbstract available
TANG F, Cao XJ, Gong T, Huang XY, et al Bronchial arterial chemoembolization/infusion combined with iodine-125
brachytherapy in advanced non-small cell lung cancer: a promising salvage therapy
after standard treatment failure.
BMC Cancer. 2025;25:750. PubMedAbstract available
HOU Y, Xue X, Zhang Z, Mai D, et al Genomic and clinical characterization of HER2 exon 20 mutations in non-small cell
lung cancer: insights from a multicenter study in South China.
BMC Cancer. 2025;25:752. PubMedAbstract available
WU S, Guo Y, Wang R Combining network pharmacology and experimental verification to explore the
inhibitory effects of Deoxyelephantopin (DET) Against Non-Small Cell Lung Cancer
(NSCLC).
BMC Cancer. 2025;25:738. PubMedAbstract available
ZHANG X, Zhang L, Geng Z, Shang M, et al Potential profile analysis of financial toxicity and its related factors among
lung cancer patients.
BMC Cancer. 2025;25:740. PubMedAbstract available
HU D, Hu Y, Lei S, Wu D, et al MET tyrosine kinase inhibitors in combination with EGFR tyrosine kinase
inhibitors in NSCLC patients with EGFR mutations and acquired MET alterations: a
systematic review and meta-analysis.
BMC Cancer. 2025;25:732. PubMedAbstract available
LIU C, He Y, Luo J The influence of image selection and segmentation on the extraction of lung
cancer imaging radiomics features using 3D-Slicer software.
BMC Cancer. 2025;25:728. PubMedAbstract available
WANG FY, Yeh YC, Lin SY, Wang SY, et al Real-world application of targeted next-generation sequencing for identifying
molecular variants in Asian non-small-cell lung cancer.
BMC Cancer. 2025;25:715. PubMedAbstract available
GAO Y, Hu P, Wu N, Tan F, et al A study protocol for the CHinA National CancEr screening (CHANCES) trial: a
randomized controlled study to compare the screening strategies for lung cancer
and colorectal cancer.
BMC Cancer. 2025;25:727. PubMedAbstract available
LIAO S, Sun H, Lu H, Wu J, et al Neutrophil-to-lymphocyte ratio-based prognostic score can predict outcomes in
patients with advanced non-small cell lung cancer treated with immunotherapy plus
chemotherapy.
BMC Cancer. 2025;25:697. PubMedAbstract available
FAN Z, Liu W, Gao Z, Liu Y, et al CMSS1: A RNA binding protein with pivotal roles in non-small cell lung cancer
progression and prognosis.
BMC Cancer. 2025;25:688. PubMedAbstract available
XU J, Zhang Z, Han K, Yang Z, et al EXOSC5: a novel biomarker for poor prognosis in lung adenocarcinoma.
BMC Cancer. 2025;25:681. PubMedAbstract available
LI Z, Miao H, Bao W, Zhang L, et al Development and validation of a nomogram model of lung metastasis in breast
cancer based on machine learning algorithm and cytokines.
BMC Cancer. 2025;25:692. PubMedAbstract available
KONDO N, Yoshiura T, Kakinohana Y, Yamashita M, et al Risk factors for radiation-induced rib fractures following proton beam therapy
for stage I non-small cell lung cancer: a retrospective study.
BMC Cancer. 2025;25:682. PubMedAbstract available
CAO W, Han S, Zhang P, Mi L, et al Immune checkpoint inhibitor-related myocarditis in patients with lung cancer.
BMC Cancer. 2025;25:685. PubMedAbstract available
LEI Y, Cao C, Tang R, Liu Y, et al Peripheral blood inflammatory biomarkers neutrophil/ lymphocyte ratio,
platelet/lymphocyte ratio and systemic immune-inflammation index/albumin ratio
predict prognosis and efficacy in non-small cell lung cancer patients receiving
immunotherapy and opi
BMC Cancer. 2025;25:664. PubMedAbstract available
MEI K, Feng Z, Liu H, Wang M, et al Preoperative prediction of pulmonary ground-glass nodule infiltration status by
CT-based radiomics combined with neural networks.
BMC Cancer. 2025;25:659. PubMedAbstract available
TAJE R, Gallina FT, Caterino M, Forcella D, et al Molecular characterization of early-stage lung adenocarcinoma presenting as
subsolid nodules in a real-life European cohort.
BMC Cancer. 2025;25:647. PubMedAbstract available
LI J, Xu HL, Li WX, Ma XY, et al Prognostic factors of survival in patients with lung cancer after low-dose
computed tomography screening: a multivariate analysis of a lung cancer screening
cohort in China.
BMC Cancer. 2025;25:646. PubMedAbstract available
XU S, Yin SY, Bie ZX, Li YM, et al Personalized drug screening of patient-derived tumor-like cell clusters based on
specimens obtained from percutaneous transthoracic needle biopsy in patients with
lung malignancy: a real-world study.
BMC Cancer. 2025;25:649. PubMedAbstract available
SANG H, Liu J, Chen X, Zeng Y, et al METTL16-dependent miR-146b-5p m6A modification remodeling sensitize NSCLC to
osimertinib via activating PI3K/AKT signaling.
BMC Cancer. 2025;25:641. PubMedAbstract available
YIN X, Lin X, Zhang G, Yin Y, et al Intensity-modulated proton therapy for hippocampal-sparing prophylactic cranial
irradiation: a planning comparison with photon therapy.
BMC Cancer. 2025;25:639. PubMedAbstract available
LI Y, Zhou J, Liu L, Zhu C, et al Association of SNPs in nAChRs genes, areca nut chewing and smoking, and their
interaction with lung cancer in Hainan, China: a case control study.
BMC Cancer. 2025;25:626. PubMedAbstract available
CAPDEVILA J, Pubul V, Anido U, Walter T, et al A Randomized clinical trial evaluating the impact on survival and quality of life
of (177)Lutetium[Lu]-edotreotide versus everolimus in patients with
neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217).
BMC Cancer. 2025;25:613. PubMedAbstract available
GUO RQ, Li YM, Bie ZX, Peng JZ, et al Microwave ablation of non-small cell lung cancer enhances local T-cell abundance
and alters monocyte interactions.
BMC Cancer. 2025;25:605. PubMedAbstract available
ZHENG W, Zhou C, Xue Z, Qiao L, et al Integrative analysis of a novel signature incorporating metabolism and
stemness-related genes for risk stratification and assessing clinical outcomes
and therapeutic responses in lung adenocarcinoma.
BMC Cancer. 2025;25:591. PubMedAbstract available
March 2025
WU S, Jiang R, Fedorowicz G, Wong M, et al Analytical validation of the Percepta Nasal Swab classifier; an RNA
next-generation sequencing assay for the assessment of lung cancer risk in
pulmonary nodules.
BMC Cancer. 2025;25:577. PubMedAbstract available
THOMPSON JJ, MacLeod N, Will S, O'Rourke F, et al The prognostic value of a laboratory cachexia score (LCAS) defined by LDH, CRP
and albumin in patients with advanced lung cancer.
BMC Cancer. 2025;25:543. PubMedAbstract available
LI S, Du F, Zhang Y, Wang Q, et al Myocarditis prediction in locally advanced or metastatic lung cancer patients
with cardiac parameters abnormalities undergoing immunotherapy: development and
validation of a risk assessment model.
BMC Cancer. 2025;25:541. PubMedAbstract available
PAN X, Deng H Deubiquitinase USP18 mediates cell migration, apoptosis and ferroptosis in lung
adenocarcinoma by depending on POU4F1/PRKAA2 axis.
BMC Cancer. 2025;25:528. PubMedAbstract available
ZHU ZY, Yun YQ, Li H, Qin ZQ, et al Subpleural injection of gelatin sponge particles to reduce pneumothorax incidence
in CT-guided lung biopsies: a retrospective single-center case-control study.
BMC Cancer. 2025;25:529. PubMedAbstract available
LIU X, Ji Z, Zhang L, Li L, et al Prediction of pathological complete response to neoadjuvant chemoimmunotherapy in
non-small cell lung cancer using (18)F-FDG PET radiomics features of primary
tumour and lymph nodes.
BMC Cancer. 2025;25:520. PubMedAbstract available
LIU X, Yin X, Zhuang L, Wen J, et al Efficacy and safety of TQB2450 combined with anlotinib as maintenance therapy for
LS-SCLC after definitive concurrent or sequential chemoradiotherapy: a
prospective phase Ib study.
BMC Cancer. 2025;25:509. PubMedAbstract available
CAO L, Li T, Xu X, Sun M, et al Texasin, A main product from Caragana Jubata (Pall.) Poir, induces proliferation
arrest and protective autophagy in lung adenocarcinoma.
BMC Cancer. 2025;25:513. PubMedAbstract available
HE D, Lu H, Ou X, Zheng T, et al Correction: Exposure to major coronary heart disease events reduces lung cancer
risk: a Mendelian randomization study based on a European population.
BMC Cancer. 2025;25:501. PubMed
LIN W, Wang Y, Li M, Feng J, et al Tumor treating fields enhance anti-PD therapy by improving CCL2/8 and
CXCL9/CXCL10 expression through inducing immunogenic cell death in NSCLC models.
BMC Cancer. 2025;25:489. PubMedAbstract available
SHI Y, Wang X, Pei Z, Shi H, et al Telpegfilgrastim for chemotherapy-induced neutropenia in patients with non-small
cell lung cancer: a multicentre, randomized, phase 3 study.
BMC Cancer. 2025;25:490. PubMedAbstract available
LI Y, Liu Y, Xie Y, Wang Y, et al Long-read RNA sequencing enables full-length chimeric transcript annotation of
transposable elements in lung adenocarcinoma.
BMC Cancer. 2025;25:482. PubMedAbstract available
LI Y, Tong Z, Yang Y, Wang Y, et al Lung Cancer Biomarker Database (LCBD): a comprehensive and curated repository of
lung cancer biomarkers.
BMC Cancer. 2025;25:478. PubMedAbstract available
ZHAO K, Lu S, Niu J, Zhu H, et al Real-world data on immunotherapy combined with chemotherapy in elderly patients
with extensive-stage small cell lung cancer.
BMC Cancer. 2025;25:467. PubMedAbstract available
CAI F, Guo Z, Wang G, Luo F, et al Integration of intratumoral and peritumoral CT radiomic features with machine
learning algorithms for predicting induction therapy response in locally advanced
non-small cell lung cancer.
BMC Cancer. 2025;25:461. PubMedAbstract available
WU T, Cai J, Li Y, Xie R, et al Validation for revision of the stage IIIA(T1N2) in the forthcoming ninth edition
of the TNM classification for lung cancer.
BMC Cancer. 2025;25:446. PubMedAbstract available
CAO P, Jia X, Wang X, Fan L, et al Deep learning radiomics for the prediction of epidermal growth factor receptor
mutation status based on MRI in brain metastasis from lung adenocarcinoma
patients.
BMC Cancer. 2025;25:443. PubMedAbstract available
WEI K, Sun T, Feng X, Chen Y, et al PD-1/L1 immune checkpoint inhibitors for KRAS-mutant non-small cell lung cancer:
a multicenter retrospective real-world study.
BMC Cancer. 2025;25:444. PubMedAbstract available
JAHANI MM, Mashayekhi P, Omrani MD, Meibody AA, et al Efficacy of liquid biopsy for genetic mutations determination in non-small cell
lung cancer: a systematic review on literatures.
BMC Cancer. 2025;25:433. PubMedAbstract available
ZHANG Z, Zhao Y, Ma YJ, Chen CQ, et al Prediction of STAS in lung adenocarcinoma with nodules = 2 cm using machine
learning: a multicenter retrospective study.
BMC Cancer. 2025;25:417. PubMedAbstract available
LAI Z, Pang Y, Zhou Y, Chen L, et al Luteolin as an adjuvant effectively enhanced the efficacy of adoptive
tumor-specific CTLs therapy.
BMC Cancer. 2025;25:411. PubMedAbstract available
LAI Y, Zhou S, Tian L, Li H, et al Preoperative heart rate variability as a predictor of postoperative pneumonia and
lung function recovery in surgical lung cancer patients: a prospective observed
study.
BMC Cancer. 2025;25:404. PubMedAbstract available
ZHANG L, Luo J, Wu X Impact of single-port versus three-port video-assisted thoracic surgery lobectomy
on postoperative pain and quality of life in early-stage non-small cell lung
cancer patients: a meta-analysis.
BMC Cancer. 2025;25:400. PubMedAbstract available
NIE X, Zou M, Song C, Zhang P, et al Survival impact and risk factors of skeletal muscle loss during first-line
EGFR-TKIs therapy in advanced lung adenocarcinoma patients.
BMC Cancer. 2025;25:393. PubMedAbstract available
SHIMA Y, Yoshida H, Suminaga K, Yoshida H, et al Safety and efficacy of pemetrexed for patients with non-small cell lung cancer in
the setting of renal impairment: a retrospective study.
BMC Cancer. 2025;25:388. PubMedAbstract available
ZHI L, Zhang Z, Gao Q, Shang C, et al Correction: CAR-NK cells with dual targeting of PD-L1 and MICA/B in lung cancer
tumor models.
BMC Cancer. 2025;25:386. PubMed
February 2025
OH JH, Lee SJ, Park YJ F-18 FDG PET-derived imaging biomarkers of airway inflammation and their clinical
associations in patients with non-small cell lung cancer.
BMC Cancer. 2025;25:379. PubMedAbstract available
HUANG F, Lin X, Hong Y, Li Y, et al The feasibility and cost-effectiveness of implementing mobile low-dose computed
tomography with an AI-based diagnostic system in underserved populations.
BMC Cancer. 2025;25:345. PubMedAbstract available
ZHI L, Zhang Z, Gao Q, Shang C, et al CAR-NK cells with dual targeting of PD-L1 and MICA/B in lung cancer tumor models.
BMC Cancer. 2025;25:337. PubMedAbstract available
GAO H, Zou X, Fan M, Chen M, et al Predictive model for sarcopenia in patients with non-small cell lung cancer and
malignant pleural effusion.
BMC Cancer. 2025;25:350. PubMedAbstract available
IEMWIMANGSA N, Anantaya D, Oranratnachai S, Thamrongjirapat T, et al Dynamic changes in immune repertoire profiles in patients with stage III
unresectable non-small cell lung cancer during consolidation treatment with
immunotherapy.
BMC Cancer. 2025;25:333. PubMedAbstract available
BAO T, Deng Y, Chen L, Sun W, et al Primary tumour resection in non-small cell lung cancer patients with pleural
dissemination unexpectedly detected during operation: a two-centre retrospective
cohort study.
BMC Cancer. 2025;25:316. PubMedAbstract available
HUANG Z, Wang H, Ting F, Chen Y, et al Metabolic and multi-model intravoxel incoherent motion parameters based (18)F-FDG
PET/MRI for predicting subtypes of inoperable non-small cell lung cancer.
BMC Cancer. 2025;25:322. PubMedAbstract available
YANG Y, Li X, Duan Y, Zhao J, et al Risk factors for malignant solid pulmonary nodules: a meta-analysis.
BMC Cancer. 2025;25:312. PubMedAbstract available
WANG X, Wu YX, Hu WP, Zhang J, et al Incidence and risk factors of serious infections occurred in patients with lung
cancer following immune checkpoint blockade therapy.
BMC Cancer. 2025;25:307. PubMedAbstract available
CHEN W, Gao P, Lu F, Wang E, et al CT texture features of lung adenocarcinoma with HER2 mutation.
BMC Cancer. 2025;25:287. PubMedAbstract available
FUKUSHIMA T, Katsushima U, Ogushi N, Hase K, et al Lower-extremity muscle strength is associated with prognosis in patients with
advanced or recurrent lung cancer: a retrospective, observational study.
BMC Cancer. 2025;25:282. PubMedAbstract available
XINJING Z, Lei G, Xinbao L, Zhonghe J, et al Prognostic importance of the neutrophil-to-lymphocyte ratio in malignant
peritoneal mesothelioma patients receiving cytoreductive surgery and hyperthermic
intraperitoneal chemotherapy.
BMC Cancer. 2025;25:270. PubMedAbstract available
WANG H, Chen K, Ma S, Huang W, et al PPIs effect in EGFR-TKI-associated interstitial lung diseases in patients with
non-small cell lung cancer.
BMC Cancer. 2025;25:263. PubMedAbstract available
YANG X, Song Y, Xu R, Yang Y, et al Prophylactic cranial irradiation improved the prognosis in pT1-2N0M0 small cell
lung cancers after complete resection: a retrospective real-world study.
BMC Cancer. 2025;25:266. PubMedAbstract available
DU CC, Sun DQ, Chen YX, Li JS, et al Study of the microenvironment of the lung flora in female lung adenocarcinoma
patients: from benign lesions to invasive lung adenocarcinomas.
BMC Cancer. 2025;25:252. PubMedAbstract available
ZHANG P, Wang L, Liu H, Lin S, et al Unveiling the crucial role of glycosylation modification in lung adenocarcinoma
metastasis through artificial neural network-based spatial multi-omics
single-cell analysis and Mendelian randomization.
BMC Cancer. 2025;25:249. PubMedAbstract available
WU D, Huang Y, Wang B, Zheng Q, et al A clinical model to predict brain metastases in resected early-stage non-small
cell lung cancer.
BMC Cancer. 2025;25:236. PubMedAbstract available
JIANG Y, Hu X, Heibi Y, Wu H, et al Exploring prognostic precision: a nomogram approach for malignant pleural
effusion in lung cancer.
BMC Cancer. 2025;25:227. PubMedAbstract available
CHEN H, Xu Y, Chen D, Xiao D, et al The Hippo pathway promotes platinum-based chemotherapy by inhibiting
MTF1-dependent heavy metal response.
BMC Cancer. 2025;25:223. PubMedAbstract available
GAO R, Liang W, Chen J, Yang M, et al Comparisons of adverse events associated with immune checkpoint inhibitors in the
treatment of non-small cell lung cancer: a real-world disproportionality analysis
based on the FDA adverse event reporting system.
BMC Cancer. 2025;25:216. PubMedAbstract available
KRAFT A, Kirschner MB, Orlowski V, Ronner M, et al Exploring RNA cargo in extracellular vesicles for pleural mesothelioma detection.
BMC Cancer. 2025;25:212. PubMedAbstract available
QU J, Chen Z, Zhu Y, Huang J, et al Pulmonary Nuclear protein in Testis (NUT) carcinoma: clinical, molecular
characteristics, and treatment strategies.
BMC Cancer. 2025;25:196. PubMedAbstract available
January 2025
ZHANG D, Liu G, Ye J, Li K, et al Low-exhaustion peripheral circulating gammadelta T cells serve as a biomarker for
predicting the clinical benefit rate of non-small cell lung cancer (NSCLC)
patients to chemotherapy or targeted therapy: a single-center retrospective
study.
BMC Cancer. 2025;25:178. PubMedAbstract available
LUO L, Ji J, Dong J, He M, et al Infiltration and subtype analysis of CD3 + CD20 + T cells in lung cancer.
BMC Cancer. 2025;25:179. PubMedAbstract available
HE D, Lu H, Ou X, Zheng T, et al Exposure to major coronary heart disease events reduces lung cancer risk: a
mendelian randomization study based on a European population.
BMC Cancer. 2025;25:152. PubMedAbstract available
TANG C, Sun SX, Gu C, Li CJ, et al Diagnostic and prognostic values of tsRNAs in lung cancer: a meta-analysis.
BMC Cancer. 2025;25:153. PubMedAbstract available
KUNCMAN L, Fijuth J, Tworek D, Sierko E, et al Radiotherapy(R) Integration(I) Strategy for Small(S)-Cell Lung Cancer in
Extensive(E) Stage (RISE) with up to 10 metastases- a study protocol of a
randomized phase II trial.
BMC Cancer. 2025;25:142. PubMedAbstract available
ZHOU Y, Zhao L, Cai M, Luo D, et al Utilizing sc-linker to integrate single-cell RNA sequencing and human genetics to
identify cell types and driver genes associated with non-small cell lung cancer.
BMC Cancer. 2025;25:130. PubMedAbstract available
NI R, Huang Y, Wang L, Chen H, et al An early lung cancer diagnosis model for non-smokers incorporating ct imaging
analysis and circulating genetically abnormal cells (CACs).
BMC Cancer. 2025;25:124. PubMedAbstract available
MA J, Xu X, Huang W, Hu Y, et al Prognostic analysis of helical tomotherapy stereotactic body radiotherapy in
multiple primary or second primary lung cancers.
BMC Cancer. 2025;25:118. PubMedAbstract available
YANG H, Li MH, Li QH, Cheng KB, et al Clinical analysis of pulmonary mucosa-associated lymphoid tissue lymphoma
coexisting with lung cancer.
BMC Cancer. 2025;25:120. PubMedAbstract available
SHIGENOBU T, Taniguchi Y, Suzuki T, Tabuchi Y, et al Surgery versus concurrent chemoradiotherapy for stage III non-small cell lung
cancer: a retrospective study with propensity score matching.
BMC Cancer. 2025;25:121. PubMedAbstract available
CHEN S, Wu S Ensemble machine learning models for lung cancer incidence risk prediction in the
elderly: a retrospective longitudinal study.
BMC Cancer. 2025;25:126. PubMedAbstract available
LIAO R, Yi G, Shen L, Xiao X, et al Characterization of the genomic landscape in liver oligometastatic NSCLC.
BMC Cancer. 2025;25:93. PubMedAbstract available
LIU X, Lv W, Huang D, Cui H, et al The predictive role of tertiary lymphoid structures in the prognosis and response
to immunotherapy of lung cancer patients: a systematic review and meta-analysis.
BMC Cancer. 2025;25:87. PubMedAbstract available
ZHANG F, Qi F, Han Y, Yang H, et al Clinical and imaging features of co-existent pulmonary tuberculosis and lung
cancer: a population-based matching study in China.
BMC Cancer. 2025;25:89. PubMedAbstract available
YANG M, Zheng G, Chen F, Tang H, et al Molecular characterization of EBV-associated primary pulmonary lymphoepithelial
carcinoma by multiomics analysis.
BMC Cancer. 2025;25:85. PubMedAbstract available
YIN W, Lin Z, Gong WJ, Wang WX, et al Smoking cessation is a protective factor for lung cancer onset and mortality: a
population-based prospective cohort study.
BMC Cancer. 2025;25:86. PubMedAbstract available
YING S, Wu N, Ruan Y, Ge W, et al IL-17 triggers PD-L1 gene transcription in NSCLC cells via TRIM31-dependent MEF2C
K63-linked polyubiquitination.
BMC Cancer. 2025;25:81. PubMedAbstract available
LUAN Y, Liang C, Han Q, Zhou X, et al The systematic analysis of genes related to butyrate metabolism suggests that
CDKN3 could serve as a promising therapeutic target for lung adenocarcinoma
treatment.
BMC Cancer. 2025;25:69. PubMedAbstract available
WANG Z, Cui W, Liang L, Qu J, et al Exploring the role of ELOVLs family in lung adenocarcinoma based on bioinformatic
analysis and experimental validation.
BMC Cancer. 2025;25:62. PubMedAbstract available
ZUO Z, Deng J, Ge W, Zhou Y, et al Quantifying intratumoral heterogeneity within sub-regions to predict high-grade
patterns in clinical stage I solid lung adenocarcinoma.
BMC Cancer. 2025;25:51. PubMedAbstract available
ZHANG R, Jiang Y, Gu J, Zhang X, et al Diagnostic role of circulating long non-coding RNA LINC00312 in patients with
non-small cell lung cancer: a retrospective study.
BMC Cancer. 2025;25:47. PubMedAbstract available
ZHAO Y, Zhou C, Zuo L, Yan H, et al Identification of cancer cell-intrinsic biomarkers associated with tumor
progression and characterization of SFTA3 as a tumor suppressor in lung
adenocarcinomas.
BMC Cancer. 2025;25:36. PubMedAbstract available
LISHCHUK P, Kuznietsova H, Dovbynchuk T, Dziubenko N, et al Impact of irradiation conditions on therapy of Lewis lung carcinoma in mice using
glucose-ethylenediamine carbon dots.
BMC Cancer. 2025;25:39. PubMedAbstract available
EVERATT R, Kuzmickiene I, Brasiuniene B, Vincerzevskiene I, et al Postdiagnostic use of antihypertensive medications and survival in colorectal,
lung, corpus uteri, melanoma and kidney cancer patients with hypertension.
BMC Cancer. 2025;25:38. PubMedAbstract available
XIONG Y, Ma Y, Lei J, Zhu J, et al Highly proliferating cancer cells function as novel prognostic biomarkers for
lung adenocarcinoma with particular usefulness for stage IA risk stratification.
BMC Cancer. 2025;25:25. PubMedAbstract available
HAMAKAWA Y, Hirahara A, Hayashi A, Ito K, et al Prognostic value of systemic immune-inflammation index in patients with
small-cell lung cancer treated with immune checkpoint inhibitors.
BMC Cancer. 2025;25:17. PubMedAbstract available
ZHU L, Liu J, Huang X, Hu J, et al Preoperative immunochemotherapy versus chemotherapy as first-line treatment for
patients with stage I-IIIB small-cell lung cancer.
BMC Cancer. 2025;25:8. PubMedAbstract available
GONG W, Vaishnani DK, Jin XC, Zeng J, et al Evaluation of an enhanced ResNet-18 classification model for rapid On-site
diagnosis in respiratory cytology.
BMC Cancer. 2025;25:10. PubMedAbstract available
LIAN Z, Liu X, Li X Elucidating the expression and role of cGAS in pan-cancer using integrated
bioinformatics and experimental approaches.
BMC Cancer. 2025;25:5. PubMedAbstract available
December 2024
LUAN T, Hao J, Gu Y, He P, et al A clinical analysis and literature review of eleven cases with primary pulmonary
angiosarcoma.
BMC Cancer. 2024;24:1597. PubMedAbstract available
BORILOVA S, Grell P, Selingerova I, Gescheidtova L, et al Early changes of peripheral circulating immune subsets induced by PD-1 inhibitors
in patients with advanced malignant melanoma and non-small cell lung cancer.
BMC Cancer. 2024;24:1590. PubMedAbstract available
WANG B, Zhang J, Shi Y, Wang Y, et al Clinical significance of the combined systemic immune-inflammatory index and
prognostic nutritional index in predicting the prognosis of patients with
extensive-stage small-cell lung cancer receiving immune-combination chemotherapy.
BMC Cancer. 2024;24:1574. PubMedAbstract available
DENG G, Zhang Q, Fan J, Zhao C, et al Optimal intervention timing for craniocerebral radiotherapy in EGFR mutant lung
adenocarcinoma patients with brain metastases.
BMC Cancer. 2024;24:1571. PubMedAbstract available
LIU Y, Geng Q, Lin X, Feng C, et al Benefits, harms, and cost-effectiveness of risk model-based and risk factor-based
low-dose computed tomography screening strategies for lung cancer: a systematic
review.
BMC Cancer. 2024;24:1567. PubMedAbstract available
MA F, Zheng W, Wang W, Zhang N, et al The mediating role of medical coping modes between stigma and quality of life in
patients undergoing lung cancer surgery: a cross-sectional study.
BMC Cancer. 2024;24:1561. PubMedAbstract available
LOCQUET M, Jacob S, Geets X, Beaudart C, et al Dose-volume predictors of cardiac adverse events after high-dose thoracic
radiation therapy for lung cancer: a systematic review and meta-analysis.
BMC Cancer. 2024;24:1556. PubMedAbstract available
XIE X, Li Y, Lv Q, Wang W, et al Immune-related adverse events correlate with the clinical efficacy in advanced
Non-Small-Cell Lung Cancer patients treated with PD-1 inhibitors combination
therapy.
BMC Cancer. 2024;24:1541. PubMedAbstract available
JIANG D, Wang Z, Li H, Liu J, et al Experiences of patient delay among lung cancer patients in South China.
BMC Cancer. 2024;24:1527. PubMedAbstract available
ZHANG W, Dai T, Wang D, Zhu Y, et al Efficacy of neoadjuvant PD-1/PD-L1 inhibitor in resectable NSCLC: a meta-analysis
based on randomized controlled trials.
BMC Cancer. 2024;24:1522. PubMedAbstract available
ZHANG Y, Zeng Y, Yin Y, Zhang W, et al The role of radiotherapy in extensive-stage small cell lung cancer: insights from
treatment failure patterns in the era of immunotherapy.
BMC Cancer. 2024;24:1534. PubMedAbstract available
MOU K, Wang H, Zhu S, Luo J, et al Comprehensive analysis of the prognostic and immunological role of cavins in
non-small cell lung cancer.
BMC Cancer. 2024;24:1525. PubMedAbstract available
SONG J, Ye X, Peng Q, Ying X, et al Correction: Circulating Tumor cells and multiple indicators combined to identify
the risk of poorer prognosis in patients with resected non-small cell lung
cancer.
BMC Cancer. 2024;24:1511. PubMed
ZHENG X, Liu K, Gao Z, Li C, et al Predicting overall survival and prophylactic cranial irradiation benefit in small
cell lung cancer patients: a multicenter cohort study.
BMC Cancer. 2024;24:1507. PubMedAbstract available
CHEN Q, Li Y, Lin Y, Lin X, et al Effectiveness of non-pharmacological interventions in managing symptom clusters
among lung cancer patients: a systematic review.
BMC Cancer. 2024;24:1505. PubMedAbstract available
ZHANG X, Sun Q, Chen R, Zhao M, et al Efficacy and safety of combining anti-angiogenic therapy, radiotherapy, and PD-1
inhibitors in patients with driver gene-negative non-small cell lung cancer brain
metastases: a retrospective study.
BMC Cancer. 2024;24:1492. PubMedAbstract available
SONG J, Ye X, Peng Q, Ying X, et al Circulating Tumor cells and multiple indicators combined to identify the risk of
poorer prognosis in patients with resected non-small cell lung cancer.
BMC Cancer. 2024;24:1491. PubMedAbstract available
November 2024
SON JW, Lee J, Jeon JH, Cho S, et al Validation of IASLC 9th edition TNM classification for lung cancer: focus on N
descriptor.
BMC Cancer. 2024;24:1460. PubMedAbstract available
DEHGHANI F, Toorang F, Seyyedsalehi MS, Sasanfar B, et al Association between the dietary inflammatory index and risk of lung cancer: a
multi-centered case-control study.
BMC Cancer. 2024;24:1452. PubMedAbstract available
LEI S, Tian L, Yang L, Yang Y, et al Efficacy and safety of RET-TKI in advanced RET-rearranged non-small cell lung
cancer in China: a real-world retrospective chart review.
BMC Cancer. 2024;24:1427. PubMedAbstract available
KOYAMA J, Morise M, Furukawa T, Oyama S, et al Artificial intelligence-based personalized survival prediction using clinical and
radiomics features in patients with advanced non-small cell lung cancer.
BMC Cancer. 2024;24:1417. PubMedAbstract available
RASMUSSEN TR, Gouliaev A, Jakobsen E, Hjorthaug K, et al Impact of multidisciplinary team discrepancies on comparative lung cancer outcome
analyses and treatment equality.
BMC Cancer. 2024;24:1423. PubMedAbstract available
BADE BC, Gan G, Li F, Lu L, et al Correction: Randomized trial of physical activity on quality of life and lung
cancer biomarkers in patients with advanced stage lung cancer: a pilot study.
BMC Cancer. 2024;24:1409. PubMed
ZHANG X, Meng J, Gao M, Gong C, et al Identifying immunohistochemical biomarkers panel for non-small cell lung cancer
in optimizing treatment and forecasting efficacy.
BMC Cancer. 2024;24:1397. PubMedAbstract available
LIU A, Wang X, Wang L, Zhuang H, et al EGFR-TKIs or EGFR-TKIs combination treatments for untreated advanced EGFR-mutated
NSCLC: a network meta-analysis.
BMC Cancer. 2024;24:1390. PubMedAbstract available
LI Y, Shi D, Jiang Y, Hu Y, et al Establishment of potential lncRNA-related hub genes involved competitive
endogenous RNA in lung adenocarcinoma.
BMC Cancer. 2024;24:1371. PubMedAbstract available
MAO Y, Chen F, Ye Z, Li Z, et al Neoadjuvant immune checkpoint inhibitor reduced recurrence in operable NSCLC
patients with pathological complete response: a retrospective analysis.
BMC Cancer. 2024;24:1366. PubMedAbstract available
ZHANG Y, Li J, Song X, Zhao F, et al Determining optimal clinical target volume margins based on microscopic
extracapsular extension of metastatic nodes in patients with non-small-cell lung
cancer after chemotherapy or chemotherapy combined with immunotherapy.
BMC Cancer. 2024;24:1368. PubMedAbstract available
CHEN Z, Yi G, Li X, Yi B, et al Predicting radiation pneumonitis in lung cancer using machine learning and
multimodal features: a systematic review and meta-analysis of diagnostic
accuracy.
BMC Cancer. 2024;24:1355. PubMedAbstract available
ZAFAR A, Rashid AA, Moeed A, Tahir MJ, et al Safety and efficacy of PD-1/PD-L1 immune checkpoint inhibitors in patients with
pre-treated advanced stage malignant mesothelioma: a systematic review and
meta-analysis.
BMC Cancer. 2024;24:1353. PubMedAbstract available
JI Y, Harris MA, Newton LM, Harris TJ, et al Osteosarcoma cells depend on MCL-1 for survival, and osteosarcoma metastases
respond to MCL-1 antagonism plus regorafenib in vivo.
BMC Cancer. 2024;24:1350. PubMedAbstract available
TANG J, Wang T, Wu H, Bao X, et al Efficacy and toxicity of lurbinectedin in subsequent systemic therapy of
extensive-stage small cell lung cancer: a meta-analysis.
BMC Cancer. 2024;24:1351. PubMedAbstract available
October 2024
WANG T, Li R, Liu S, Wu Q, et al The effects of immune checkpoint inhibitors vs. chemotherapy combined with brain
radiotherapy in non-small cell lung cancer patients with brain metastases.
BMC Cancer. 2024;24:1343. PubMedAbstract available
SESTER S, Wilms G, Ahlburg J, Babendreyer A, et al Elevated expression levels of the protein kinase DYRK1B induce mesenchymal
features in A549 lung cancer cells.
BMC Cancer. 2024;24:1341. PubMedAbstract available
XIONG Y, Wang L, Zhang W, Meng Y, et al First-line treatment with gefitinib in combination with bevacizumab and
chemotherapy in advanced non-squamous NSCLC with EGFR-mutation.
BMC Cancer. 2024;24:1326. PubMedAbstract available
WU DN, Zhang KL, Chen RH, Ye WS, et al VASN promotes the aggressive phenotype in ARID1A-deficient lung adenocarcinoma.
BMC Cancer. 2024;24:1327. PubMedAbstract available
TANG Y, Zhao S, Zhou L, Huang Y, et al A 16-year evaluation of opportunistic lung cancer screening with low-dose CT in
China: comparative findings between non-smokers and smokers.
BMC Cancer. 2024;24:1322. PubMedAbstract available
SHEN F, Wu X, Geng J, Guo W, et al Prognostic factors for resected invasive mucinous lung adenocarcinoma: a
systematic review and meta-analysis.
BMC Cancer. 2024;24:1317. PubMedAbstract available
SANTORO A, Pilar G, Tan DSW, Zugazagoitia J, et al Spartalizumab in combination with platinum-doublet chemotherapy with or without
canakinumab in patients with PD-L1-unselected, metastatic NSCLC.
BMC Cancer. 2024;24:1307. PubMedAbstract available
TONG Y, Wan X, Yin C, Lei T, et al In-depth exploration of the focus issues of TKI combined with radiotherapy for
EGFR-mutant lung adenocarcinoma patients with brain metastasis: a systematic
analysis based on literature metrology, meta-analysis, and real-world
observational data.
BMC Cancer. 2024;24:1305. PubMedAbstract available
MENG F, Ren N, Zhang G, Xu R, et al Comprehensive analysis of surgical strategies and prognosis for non-small cell
lung cancer with pleural metastasis detected intraoperatively.
BMC Cancer. 2024;24:1303. PubMedAbstract available
SAITO Y, Takekuma Y, Sakakibara-Konishi J, Shimizu Y, et al Effect of baseline anemia on the efficacy of docetaxel and ramucirumab for
advanced non-small cell lung cancer treatment.
BMC Cancer. 2024;24:1301. PubMedAbstract available
SUGAI K, Mori T, Bilal T, Furukawa A, et al Detection of circulating tumor cells in patients with lung cancer using a rare
cell sorter: a pilot study.
BMC Cancer. 2024;24:1291. PubMedAbstract available
WANG F, Liu J, Liao W, Zheng L, et al Matrine alkaloids modulating DNA damage repair in chemoresistant non-small cell
lung cancer cells.
BMC Cancer. 2024;24:1283. PubMedAbstract available
YU Q, Yang H, Xiao F, Wang Z, et al Network meta-analysis on the efficacy and safety of management for resectable
stage IIIA-N2 non-small cell lung cancer.
BMC Cancer. 2024;24:1286. PubMedAbstract available
DING D, Shang W, Shi K, Ying J, et al FTO/m6A mediates miR-138-5p maturation and regulates gefitinib resistance of lung
adenocarcinoma cells by miR-138-5p/LCN2 axis.
BMC Cancer. 2024;24:1270. PubMedAbstract available
HEMEAD H, Aly RG, Kotb M, Abdelaziz A, et al Pediatric pleuropulmonary blastoma: analysis of four cases.
BMC Cancer. 2024;24:1268. PubMedAbstract available
HOU Q, Liang Y, Yao N, Liu J, et al Development of a novel nomogram for patients with SCLC and comparison with other
models.
BMC Cancer. 2024;24:1257. PubMedAbstract available
SHEN Z, Huang Z, Zhu T, Zhang J, et al Optimal surgical timing for lung cancer following SARS-CoV-2 infection: a
prospective multicenter cohort study.
BMC Cancer. 2024;24:1250. PubMedAbstract available
CHENG H, Wang X, Yao J, Guo N, et al Assessing the causal relationship between non-small cell lung cancer and sepsis:
a Mendelian randomization study.
BMC Cancer. 2024;24:1233. PubMedAbstract available
ZHANG L, Wang S, Wang L Comprehensive analysis identifies YKT6 as a potential prognostic and diagnostic
biomarker in lung adenocarcinoma.
BMC Cancer. 2024;24:1235. PubMedAbstract available
WU D, Li Y, Zhou M, Gong F, et al Deep learning-based characterization of pathological subtypes in lung invasive
adenocarcinoma utilizing (18)F-deoxyglucose positron emission tomography imaging.
BMC Cancer. 2024;24:1229. PubMedAbstract available
ZHU X, Shen C, Dong J A clinically applicable model more suitable for predicting malignancy or
benignity of pulmonary ground glass nodules in women patients.
BMC Cancer. 2024;24:1225. PubMedAbstract available
YILMAZ F, Yasar S, Tatar OD, Yildirim HC, et al Bi-weekly irinotecan is an effective and convenient regimen in the treatment of
relapsed or refractory small cell lung cancer.
BMC Cancer. 2024;24:1218. PubMedAbstract available
September 2024
SUN M, Ji H, Deng F, Li J, et al Clinical outcomes and synergistic effect between radiotherapy and immunotherapy
in patients with extensive-stage small cell lung cancer: a real-world study.
BMC Cancer. 2024;24:1206. PubMedAbstract available
BOZCUK HS, Artac M A simulated trial with reinforcement learning for the efficacy of Irinotecan and
Ifosfamide versus Topotecan in relapsed, extensive stage small cell lung cancer.
BMC Cancer. 2024;24:1207. PubMedAbstract available
DING W, Xu T, Xiang H, Liang J, et al Is clinical target volume necessary for locally advanced non-small cell lung
cancer treated with 4D-CT intensity-modulated radiation therapy.
BMC Cancer. 2024;24:1198. PubMedAbstract available
LI H, Fu X, Liu M, Chen J, et al Novel prediction model of early screening lung adenocarcinoma with pulmonary
fibrosis based on haematological index.
BMC Cancer. 2024;24:1178. PubMedAbstract available
WANG W, Wu G, Luo W, Lin L, et al Anlotinib plus oral fluoropyrimidine S-1 in refractory or relapsed small-cell
lung cancer (SALTER TRIAL): a multicenter, single-arm, phase II trial.
BMC Cancer. 2024;24:1182. PubMedAbstract available
DENG JY, Yang MY, Yang XR, Chen ZH, et al Patterns of failure and the subsequent treatment after progression on first-line
immunotherapy monotherapy in advanced non-small cell lung cancer: a retrospective
study.
BMC Cancer. 2024;24:1190. PubMedAbstract available
TOORANG F, Seyyedsalehi MS, Sasanfar B, Rashidian H, et al Dietary total antioxidant capacity and odds of lung cancer: a large case-control
study.
BMC Cancer. 2024;24:1196. PubMedAbstract available
HUSSEIN NA, Ebied SA, Belal AAM, Ahmad MA, et al Expression profiling of circulating lncRNA GIAT4RA, lncRNA AATBC, lncRNA
Sirt1-AS, and SMARCB1 in lung cancer patients.
BMC Cancer. 2024;24:1175. PubMedAbstract available
DENG Y, Chen X, Chen X, Huang C, et al UBE2T promotes stage I lung adenocarcinoma progression through PBX1
ubiquitination and PBX1/RORA regulation.
BMC Cancer. 2024;24:1158. PubMedAbstract available
XU S, Chen X, Ying H, Chen J, et al Multi?omics identification of a signature based on malignant cell-associated
ligand-receptor genes for lung adenocarcinoma.
BMC Cancer. 2024;24:1138. PubMedAbstract available
CUI J, An Z, Zhou X, Zhang X, et al Prognosis and risk factor assessment of patients with advanced lung cancer with
low socioeconomic status: model development and validation.
BMC Cancer. 2024;24:1128. PubMedAbstract available
LIU R, Wang J, Zhang L, Wang S, et al GLIDR-mediated regulation of tumor malignancy and cisplatin resistance in
non-small cell lung cancer via the miR-342-5p/PPARGC1A axis.
BMC Cancer. 2024;24:1126. PubMedAbstract available
RUCO A, Lofters AK, Lu H, Baxter NN, et al Lung cancer survival by immigrant status: a population-based retrospective cohort
study in Ontario, Canada.
BMC Cancer. 2024;24:1114. PubMedAbstract available
HAGHIGHIKIAN SM, Shirinzadeh-Dastgiri A, Ershadi R, Vakili-Ojarood M, et al Correlation of TNF-alpha polymorphisms with susceptibility to lung cancer: evidence
from a meta-analysis based on 29 studies.
BMC Cancer. 2024;24:1113. PubMedAbstract available
WANG W, Zhang X, Gui P, Zou Q, et al SEPT9: From pan-cancer to lung squamous cell carcinoma.
BMC Cancer. 2024;24:1105. PubMedAbstract available
YANG D, Yang Y, Zhao M, Ji H, et al Evaluation of the invasiveness of pure ground-glass nodules based on dual-head
ResNet technique.
BMC Cancer. 2024;24:1080. PubMedAbstract available
BEFFA ED, Lyberis P, Rosboch GL, Arezzo A, et al Study protocol for Near-infrared molecular imaging for lung cancer detection and
treatment during mini-invasive surgery (phase II Trial) - (the RECOGNISE study).
BMC Cancer. 2024;24:1078. PubMedAbstract available
August 2024
XU S, Zheng Y, Ye M, Shen T, et al Comprehensive pan-cancer analysis reveals EPHB2 is a novel predictive biomarker
for prognosis and immunotherapy response.
BMC Cancer. 2024;24:1064. PubMedAbstract available
LI Q, Liang N, Ouyang W, Su S, et al Appropriate delay of primary tumour radiotherapy may lead to better long-term
overall survival for non-small cell lung cancer treated with EGFR-TKIs.
BMC Cancer. 2024;24:1053. PubMedAbstract available
SHI Y, Xu Y, Wang M Current clinical practice and physicians' insights on Chinese patients with
advanced non-small cell lung cancer habouring epidermal growth factor receptor 20
insertion mutation.
BMC Cancer. 2024;24:1043. PubMedAbstract available
HOSOYA K, Ozasa H, Tanji M, Yoshida H, et al Performance status improvement and advances in systemic treatment after brain
metastases resection: a retrospective single-center cohort study of non-small
cell lung cancer patients.
BMC Cancer. 2024;24:1030. PubMedAbstract available
LUO LL, Cao Y, Zhang JJ, Xie YX, et al The role of tRF-Val-CAC-010 in lung adenocarcinoma: implications for
tumorigenesis and metastasis.
BMC Cancer. 2024;24:1033. PubMedAbstract available
WU W, Yu S, Huang J, Qi Q, et al Molecular heterogeneity and treatment outcome of EGFR exon 20 insertion mutations
in Chinese patients with advanced non-small cell lung cancer: insights from a
large-scale real-world study.
BMC Cancer. 2024;24:1010. PubMedAbstract available
SHAN H, Wang X, Yin F, Zhou Y, et al Combination of transcriptome and Mendelian inheritance reveals novel prognostic
biomarker of CTLA-4-related lncRNAs and protective role of nitrogen metabolism
pathway in lung adenocarcinoma development.
BMC Cancer. 2024;24:1009. PubMedAbstract available
PARK JO, Feng YH, Su WC, Oh DY, et al Erdafitinib in Asian patients with advanced solid tumors: an open-label,
single-arm, phase IIa trial.
BMC Cancer. 2024;24:1006. PubMedAbstract available
AHSAN S, Win TT, Aye SN, Than NN, et al The role of circular RNAs (circRNAs) as a prognostic factor in lung cancer: a
meta-analysis.
BMC Cancer. 2024;24:988. PubMedAbstract available
SUN V, Guthrie KA, Arnold KB, Antonoff M, et al Comparative effectiveness of perioperative physical activity in older adults with
lung cancer and their family caregivers: design of a multicenter pragmatic
randomized trial.
BMC Cancer. 2024;24:976. PubMedAbstract available
MA Z, Liu Y, Bao Y, Liu Q, et al Higher immune cell radiation dose is correlated with poor tumor control and
survival in patients with non-small cell lung cancer receiving postoperative
radiotherapy.
BMC Cancer. 2024;24:968. PubMedAbstract available
ZHANG J, Lv PY, Zhao X, Liu ML, et al Real-world effectiveness and safety of recombinant human endostatin plus PD-1
inhibitors and chemotherapy as first-line treatment for EGFR/ALK-negative,
advanced or metastatic non-small cell lung cancer.
BMC Cancer. 2024;24:967. PubMedAbstract available
KENNEDY K, Jusue-Torres I, Buller ID, Rossi E, et al Neighborhood-level deprivation and survival in lung cancer.
BMC Cancer. 2024;24:959. PubMedAbstract available
AKDOGAN O, Ogut B, Sutcuoglu O, Sert A, et al The impact of the expression level of growth differentiation factor 15 in tumor
tissue on the response to immunotherapy in non-small cell lung cancer.
BMC Cancer. 2024;24:954. PubMedAbstract available
YAO N, Qin Z, Chen M, Hu L, et al Effects of brain radiotherapy strategies on survival in the era of MRI for
patients with limited stage small cell lung cancer.
BMC Cancer. 2024;24:953. PubMedAbstract available
GARRIDO J, Bernal Y, Gonzalez E, Blanco A, et al Beyond tobacco: genomic disparities in lung cancer between smokers and
never-smokers.
BMC Cancer. 2024;24:951. PubMedAbstract available
QIN H, Yan H, Chen Y, Xu Q, et al Clinical outcomes for immune checkpoint inhibitors plus chemotherapy in
non-small-cell lung cancer patients with uncommon driver gene alterations.
BMC Cancer. 2024;24:952. PubMedAbstract available
LAHMADI M, Beddar L, Ketit S, Makhbouche T, et al Clinicopathological characteristics and prognosis of non-small cell lung cancer
in Algeria: a single-center retrospective study.
BMC Cancer. 2024;24:946. PubMedAbstract available
DENG H, Wang L, Li Z, Zhan T, et al Optimal treatment strategies for hepatoid adenocarcinoma of the lung: insights
from a comprehensive analysis.
BMC Cancer. 2024;24:948. PubMedAbstract available
MCINNERNEY D, Quaife SL, Cooke S, Mitchinson L, et al Understanding the impact of distance and disadvantage on lung cancer care and
outcomes: a study protocol.
BMC Cancer. 2024;24:942. PubMedAbstract available
CHEN F, Ren P, Xu R, Zhang J, et al FAM65A promotes the progression and growth of lung squamous cell carcinoma in
vivo and vitro.
BMC Cancer. 2024;24:944. PubMedAbstract available
KASEDA K, Asakura K, Shintani Y, Okami J, et al Surgically resected sarcomatoid carcinoma of the lung: a nationwide retrospective
study in 2010.
BMC Cancer. 2024;24:938. PubMedAbstract available
FRAK M, Grenda A, Krawczyk P, Kuznar-Kaminska B, et al The influence of nutritional status, lipid profile, leptin concentration and
polymorphism of genes encoding leptin and neuropeptide Y on the effectiveness of
immunotherapy in advanced NSCLC patients.
BMC Cancer. 2024;24:937. PubMedAbstract available
July 2024
GE QY, Zheng C, Zhang GC, Cong ZZ, et al Establishment and verification of novel TNM staging system for lung mucinous
adenocarcinoma.
BMC Cancer. 2024;24:925. PubMedAbstract available
LI Z, Wang J, Deng L, Zhai Y, et al Hippocampal avoidance whole-brain radiotherapy with simultaneous integrated boost
in lung cancer brain metastases and utility of the Hopkins verbal learning test
for testing cognitive impairment in Chinese patients: a prospective phase II
study.
BMC Cancer. 2024;24:899. PubMedAbstract available
TOKITO T, Kolesnik O, Sorensen J, Artac M, et al Epacadostat plus pembrolizumab versus placebo plus pembrolizumab as first-line
treatment for metastatic non-small cell lung cancer with high levels of
programmed death-ligand 1: a randomized, double-blind phase 2 study.
BMC Cancer. 2024;23. PubMedAbstract available
BOYER M, Hui R, Urban D, Clingan P, et al Pembrolizumab with platinum-based chemotherapy with or without epacadostat as
first-line treatment for metastatic non-small cell lung cancer: a randomized,
partially double-blind, placebo-controlled phase II study.
BMC Cancer. 2024;23. PubMedAbstract available
WEN Y, Wu W, Liufu Y, Pan X, et al Differentiation of granulomatous nodules with lobulation and spiculation signs
from solid lung adenocarcinomas using a CT deep learning model.
BMC Cancer. 2024;24:875. PubMedAbstract available
YAN W, Yang H, Duan D, Wu Y, et al Bone marrow mesenchymal stem cells-derived exosomal miR-145-5p reduced non-small
cell lung cancer cell progression by targeting SOX9.
BMC Cancer. 2024;24:883. PubMedAbstract available
HUI W, Gao Z, Zhu M, Wu H, et al Reply to "Matters arising: cost-effectiveness of first-line immunotherapy
combinations with or without chemotherapy for advanced non-small cell lung
cancer: a modelling approach".
BMC Cancer. 2024;24:881. PubMedAbstract available
LEARY A, Estevez-Garcia P, Sabatier R, Ray-Coquard I, et al ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer
Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients
with advanced/recurrent endometrial cancer.
BMC Cancer. 2024;24:876. PubMedAbstract available
BULLEMENT A, Edmondson-Jones M, Latimer N Cost-effectiveness of first-line immunotherapy combinations with or without
chemotherapy for advanced non-small cell lung cancer: a modelling approach.
BMC Cancer. 2024;24:879. PubMed
WANG Y, Chen R, Guo Z, Wei W, et al Immunological profiling for short-term predictive analysis in PD-1/PD-L1 therapy
for lung cancer.
BMC Cancer. 2024;24:851. PubMedAbstract available
WU G, Liu J, Shi H, Pan B, et al The associations between dysregulation of human blood metabolites and lung cancer
risk: evidence from genetic data.
BMC Cancer. 2024;24:854. PubMedAbstract available
CHEN Y, Wu S, Han Y, Shi H, et al LncRNA SH3PXD2A-AS1 facilitates cisplatin resistance in non-small cell lung
cancer by regulating FOXM1 succinylation.
BMC Cancer. 2024;24:848. PubMedAbstract available
YAMAGUCHI T, Shimizu J, Matsuzawa R, Watanabe N, et al Efficacy of chemotherapy plus immune checkpoint inhibitors in patients with
non-small cell lung cancer who have rare oncogenic driver mutations: a
retrospective analysis.
BMC Cancer. 2024;24:842. PubMedAbstract available
BIAN Y, Liu H, Huang J, Feng Z, et al eHSP90alpha in front-line therapy in EGFR exon 19 deletion and 21 Leu858Arg mutations
in advanced lung adenocarcinoma.
BMC Cancer. 2024;24:835. PubMedAbstract available
MA L, Li R, Liu X, Yu W, et al Prognostic and clinicopathological significance of tertiary lymphoid structure in
non-small cell lung cancer: a systematic review and meta-analysis.
BMC Cancer. 2024;24:815. PubMedAbstract available
LIN P, Zhang L, Tang X, Wang J, et al Exploring the causal association between uric acid and lung cancer in east Asian
and European populations: a mendelian randomization study.
BMC Cancer. 2024;24:801. PubMedAbstract available
YAN L, Su H, Liu J, Wen X, et al Rapid detection of lung cancer based on serum Raman spectroscopy and a support
vector machine: a case-control study.
BMC Cancer. 2024;24:791. PubMedAbstract available
June 2024
CHENG Y, Zhang C, Li Q, Yang X, et al MTF1 genetic variants are associated with lung cancer risk in the Chinese Han
population.
BMC Cancer. 2024;24:778. PubMedAbstract available
FAN X, Zhong R, Liang H, Zhong Q, et al Exhaled VOC detection in lung cancer screening: a comprehensive meta-analysis.
BMC Cancer. 2024;24:775. PubMedAbstract available
XIAO X, Sun Z, Liang S, Li W, et al Liquid-based cytology specimens for next-generation sequencing in lung
adenocarcinoma: challenges and evaluation of targeted therapy.
BMC Cancer. 2024;24:749. PubMedAbstract available
ZHANG B, Liu H, Shi C, Gao Z, et al Safety and efficacy of multi-target TKI combined with nivolumab in check-point
inhibitor-refractory patients with advanced NSCLC: a prospective, single-arm,
two-stage study.
BMC Cancer. 2024;24:715. PubMedAbstract available
SONG L, Wu D, Wu J, Zhang J, et al Investigating causal associations between pneumonia and lung cancer using a
bidirectional mendelian randomization framework.
BMC Cancer. 2024;24:721. PubMedAbstract available
HUI W, Li W, Song R, Xin Y, et al Time-dependent efficacy analysis of first-line immunotherapies for advanced
non-small cell lung cancer.
BMC Cancer. 2024;24:684. PubMedAbstract available
LIU Y, Huang J, Chen JC, Chen W, et al Predicting treatment response in multicenter non-small cell lung cancer patients
based on federated learning.
BMC Cancer. 2024;24:688. PubMedAbstract available
BIYU H, Mengshan L, Yuxin H, Ming Z, et al A miRNA-disease association prediction model based on tree-path global feature
extraction and fully connected artificial neural network with multi-head
self-attention mechanism.
BMC Cancer. 2024;24:683. PubMedAbstract available
ZHAO J, Lu Y, Ren X, Bian T, et al Association of the SHOX2 and RASSF1A methylation levels with the pathological
evolution of early-stage lung adenocarcinoma.
BMC Cancer. 2024;24:687. PubMedAbstract available
SONG W, Li Y, Yao Y, Sun S, et al Systematic druggable genome-wide Mendelian randomization identifies therapeutic
targets for lung cancer.
BMC Cancer. 2024;24:680. PubMedAbstract available
YANG L, Jiang Z, Tong J, Li N, et al Development and validation of a preoperative CT?based radiomics nomogram to
differentiate tuberculosis granulomas from lung adenocarcinomas: an external
validation study.
BMC Cancer. 2024;24:670. PubMedAbstract available
May 2024
LU F, Wang E, Liu H Factors correlating the expression of PD-L1.
BMC Cancer. 2024;24:642. PubMedAbstract available
ZHAO W, Liu Y, Yang Y, Wang L, et al New link between RNH1 and E2F1: regulates the development of lung adenocarcinoma.
BMC Cancer. 2024;24:635. PubMedAbstract available
HAYASHI Y, Ueyama A, Funaki S, Jinushi K, et al In situ analysis of CCR8(+) regulatory T cells in lung cancer: suppression of
GzmB(+) CD8(+) T cells and prognostic marker implications.
BMC Cancer. 2024;24:627. PubMedAbstract available
LI W, Wu J, Jia Q, Shi Y, et al PD-L1 knockdown suppresses vasculogenic mimicry of non-small cell lung cancer by
modulating ZEB1-triggered EMT.
BMC Cancer. 2024;24:633. PubMedAbstract available
LIN X, Wang F, Li Y, Lei F, et al Exploring shared decision-making needs in lung cancer screening among high-risk
groups and health care providers in China: a qualitative study.
BMC Cancer. 2024;24:613. PubMedAbstract available
PRETE M, Ballarin G, Porciello G, Arianna A, et al Bioelectrical impedance analysis-derived phase angle (PhA) in lung cancer
patients: a systematic review.
BMC Cancer. 2024;24:608. PubMedAbstract available
LIAO S, Wang Y, Zhou J, Liu Y, et al Associations between chronic obstructive pulmonary disease and ten common
cancers: novel insights from Mendelian randomization analyses.
BMC Cancer. 2024;24:601. PubMedAbstract available
PANG H, Dai L, Chen L, Chen X, et al Prognostic value of the advanced lung cancer inflammation index in patients with
gastric cancer after radical gastrectomy: a propensity-score matching cohort
study and meta-analysis.
BMC Cancer. 2024;24:583. PubMedAbstract available
GU C, Teng X, Sun X, Liu J, et al Impact of treatment interval between neoadjuvant immunochemotherapy and surgery
in lung squamous cell carcinoma.
BMC Cancer. 2024;24:585. PubMedAbstract available
WANG M, Jing X, Chen F, Lu S, et al Immune checkpoint inhibitor (ICI)-based treatment beyond progression with prior
immunotherapy in patients with driver-gene negative advanced non-small cell lung
cancer.
BMC Cancer. 2024;24:569. PubMedAbstract available
XIA L, Lin H, Cao H, Lian J, et al Tenascin C as a novel zinc finger protein 750 target regulating the
immunogenicity via DNA damage in lung squamous cell carcinoma.
BMC Cancer. 2024;24:561. PubMedAbstract available
April 2024
CUNNINGHAM R, Stanley J, Imlach F, Haitana T, et al Cancer diagnosis after emergency presentations in people with mental health and
substance use conditions: a national cohort study.
BMC Cancer. 2024;24:546. PubMedAbstract available
VIANA VELOSO GG, Amaral FD, Nogueira-Rodrigues A Impact of COVID-19 pandemic among patients with lung and head and neck cancer
assisted in a public cancer center in Brazil.
BMC Cancer. 2024;24:539. PubMedAbstract available
DENG Z, Liu X, Wu R, Yan H, et al Ultrasound-based radiomics machine learning models for diagnosing cervical lymph
node metastasis in patients with non-small cell lung cancer: a multicentre study.
BMC Cancer. 2024;24:536. PubMedAbstract available
LI Y, Gong B, Guo Y, Liu W, et al Non-small cell lung cancer and immune checkpoint inhibitor therapy: does
non-alcoholic fatty liver disease have an effect?
BMC Cancer. 2024;24:535. PubMedAbstract available
GUO Y, Pan Y, Wan J, Gong B, et al Prognosis stratification of cancer patients treated with immune checkpoint
inhibitors through lung immune prognostic index: a meta-analysis and systematic
review.
BMC Cancer. 2024;24:523. PubMedAbstract available
OKAYAMA T, Suzuki K, Morishita S, Inoue J, et al Correction: Pretreatment quality of life and survival in patients with lung
cancer: a systematic review and meta-analysis.
BMC Cancer. 2024;24:529. PubMed
SKURIKHIN E, Ermakova N, Zhukova M, Pan E, et al Effects of reprogrammed splenic CD8(+) T-cells in vitro and in mice with
spontaneous metastatic Lewis lung carcinoma.
BMC Cancer. 2024;24:522. PubMedAbstract available
SHI MX, Ding X, Tang L, Cao WJ, et al PROTAC EZH2 degrader-1 overcomes the resistance of podophyllotoxin derivatives in
refractory small cell lung cancer with leptomeningeal metastasis.
BMC Cancer. 2024;24:504. PubMedAbstract available
HE M, Jiang W, Li X, Liu H, et al 25-hydroxycholesterol promotes proliferation and metastasis of lung
adenocarcinoma cells by regulating ERbeta/TNFRSF17 axis.
BMC Cancer. 2024;24:505. PubMedAbstract available
OKAYAMA T, Suzuki K, Morishita S, Inoue J, et al Pretreatment quality of life and survival in patients with lung cancer: a
systematic review and meta-analysis.
BMC Cancer. 2024;24:495. PubMedAbstract available
XU K, Lu W, Yu A, Wu H, et al Effect of the STK11 mutation on therapeutic efficacy and prognosis in patients
with non-small cell lung cancer: a comprehensive study based on meta-analyses and
bioinformatics analyses.
BMC Cancer. 2024;24:491. PubMedAbstract available
MIMURA C, Takamiya R, Fujimoto S, Fukui T, et al Utility of bronchoscopically obtained frozen cytology pellets for next-generation
sequencing.
BMC Cancer. 2024;24:489. PubMedAbstract available
LI Y, Chen Z, Tian S, Han X, et al Stereotactic ablative brachytherapy versus percutaneous microwave ablation as
salvage treatments for lung oligometastasis from colorectal cancer.
BMC Cancer. 2024;24:481. PubMedAbstract available
MIAO SN, Chai MQ, Liu XY, Wei CY, et al Exercise accelerates recruitment of CD8(+) T cell to promotes anti-tumor immunity
in lung cancer via epinephrine.
BMC Cancer. 2024;24:474. PubMedAbstract available
WU JR, Chen VC, Fang YH, Hsieh CC, et al The associates of anxiety among lung cancer patients: Dehydroepiandrosterone
(DHEA) as a potential biomarker.
BMC Cancer. 2024;24:476. PubMedAbstract available
ZHANG D, Liu H, Zhao F, Guo P, et al Exploring the relationship between Treg-mediated risk in COPD and lung cancer
through Mendelian randomization analysis and scRNA-seq data integration.
BMC Cancer. 2024;24:453. PubMedAbstract available
HUANG Y, Chen D, Bai Y, Zhang Y, et al ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental
validation.
BMC Cancer. 2024;24:452. PubMedAbstract available
KONG C, Yin X, Zou J, Ma C, et al The application of different machine learning models based on PET/CT images and
EGFR in predicting brain metastasis of adenocarcinoma of the lung.
BMC Cancer. 2024;24:454. PubMedAbstract available
ARIMURA K, Kammer M, Rahman SMJ, Sheau-Chiann C, et al Elucidating the role of EPPK1 in lung adenocarcinoma development.
BMC Cancer. 2024;24:441. PubMedAbstract available
YANG Y, Xu J, Wang W, Ma M, et al A nomogram based on the quantitative and qualitative features of CT imaging for
the prediction of the invasiveness of ground glass nodules in lung
adenocarcinoma.
BMC Cancer. 2024;24:438. PubMedAbstract available
JIANG H, Li B, Wu M, Wang Q, et al Association of the Advanced Lung Cancer Inflammation Index (ALI) and Gustave
Roussy Immune (GRIm) score with immune checkpoint inhibitor efficacy in patients
with gastrointestinal and lung cancer.
BMC Cancer. 2024;24:428. PubMedAbstract available
LI H, Li L, Liu Y, Deng Y, et al Predictive value of CT and (18)F-FDG PET/CT features on spread through air space
in lung adenocarcinoma.
BMC Cancer. 2024;24:434. PubMedAbstract available
CHEN M, Li R, Kong Y, Shi L, et al Rational and design of prophylactic cranial irradiation (PCI) and brain MRI
surveillance versus brain MRI surveillance alone in patients with limited-stage
small cell lung cancer achieving complete remission (CR) of tumor after
chemoradiotherapy: a mu
BMC Cancer. 2024;24:429. PubMedAbstract available
DIVAN HA, Bittoni MA, Krishna A, Carbone DP, et al Real-world patient characteristics and treatment patterns in US patients with
advanced non-small cell lung cancer.
BMC Cancer. 2024;24:424. PubMedAbstract available
MENNECIER B, Khalifa J, Descourt R, Greillier L, et al Real-life clinical management patterns in extensive-stage small cell lung cancer
across France: a multi-method study.
BMC Cancer. 2024;24:421. PubMedAbstract available
BOUTABBA A, Missaoui F, Dlala A, Kamoun H, et al Circulating miR-16-5p, miR-92a-3p and miR-451a are biomarkers of lung cancer in
Tunisian patients.
BMC Cancer. 2024;24:417. PubMedAbstract available
YANG F, Zheng Y, Luo Q, Zhang S, et al Knockdown of NCAPD3 inhibits the tumorigenesis of non-small cell lung cancer by
regulation of the PI3K/Akt pathway.
BMC Cancer. 2024;24:408. PubMedAbstract available
SHENG M, Sun R, Fu J, Lu G, et al The podoplanin-CLEC-2 interaction promotes platelet-mediated melanoma pulmonary
metastasis.
BMC Cancer. 2024;24:399. PubMedAbstract available
March 2024
ZENG A, Yin Y, Xu Z, Abuduwayiti A, et al Down-regulated HHLA2 enhances neoadjuvant immunotherapy efficacy in patients with
non-small cell lung cancer (NSCLC) with chronic obstructive pulmonary disease
(COPD).
BMC Cancer. 2024;24:396. PubMedAbstract available
WEI Q, Deng T, Wu J, Zeng H, et al Immune checkpoint inhibitor plus chemotherapy as first-line treatment for
non-small cell lung cancer with malignant pleural effusion: a retrospective
multicenter study.
BMC Cancer. 2024;24:393. PubMedAbstract available
ELBASHEER MMA, Bohrmann B, Chen Y, Lv J, et al Reproductive factors and risk of lung cancer among 300,000 Chinese female
never-smokers: evidence from the China Kadoorie Biobank study.
BMC Cancer. 2024;24:384. PubMedAbstract available
XIE M, Gao J, Ma X, Song J, et al The radiological characteristics, tertiary lymphoid structures, and survival
status associated with EGFR mutation in patients with subsolid nodules like stage
I-II LUAD.
BMC Cancer. 2024;24:372. PubMedAbstract available
LI LX, Socinski MA, Kichenadasse G, Karapetis CS, et al A lack of association between BMI and chemoimmunotherapy efficacy in advanced
non-small cell lung cancer: Secondary analysis of the IMpower150 and IMpower130
clinical trials.
BMC Cancer. 2024;24:379. PubMedAbstract available
QI H, Hou Y, Zheng Z, Zheng M, et al Clinical characteristics and MRI based radiomics nomograms can predict iPFS and
short-term efficacy of third-generation EGFR-TKI in EGFR-mutated lung
adenocarcinoma with brain metastases.
BMC Cancer. 2024;24:362. PubMedAbstract available
PAN J, Wang J, Tao W, Wang C, et al Is low-dose computed tomography for lung cancer screening conveniently accessible
in China? A spatial analysis based on cross-sectional survey.
BMC Cancer. 2024;24:342. PubMedAbstract available
WANG S, Oliveira-Silveira J, Fang G, Kang J, et al High-content analysis identified synergistic drug interactions between INK128, an
mTOR inhibitor, and HDAC inhibitors in a non-small cell lung cancer cell line.
BMC Cancer. 2024;24:335. PubMedAbstract available
KAHM YJ, Kim IG, Kim RK Regulation of cancer stem cells by CXCL1, a chemokine whose secretion is
controlled by MCM2.
BMC Cancer. 2024;24:319. PubMedAbstract available
WU C, Cao B, He G, Li Y, et al Stereotactic ablative brachytherapy versus percutaneous microwave ablation for
early-stage non-small cell lung cancer: a multicenter retrospective study.
BMC Cancer. 2024;24:304. PubMedAbstract available
CHENG M, Shao Y, Li L, Jiang M, et al Cost-effectiveness of immunotherapies for advanced squamous non-small cell lung
cancer: a systematic review.
BMC Cancer. 2024;24:312. PubMedAbstract available
ZHOU J, Yu B, Guo P, Wang S, et al The insufficiency of CT examination in early detection of central lung squamous
cell carcinoma and squamous epithelial precancerous lesions.
BMC Cancer. 2024;24:299. PubMedAbstract available
WANG Y, Ouyang S, Liu M, Si Q, et al Humoral immune response to tumor-associated antigen Ubiquilin 1 (UBQLN1) and its
tumor-promoting potential in lung cancer.
BMC Cancer. 2024;24:283. PubMedAbstract available
LIU J, Bian T, She B, Liu L, et al Evaluating the comprehensive diagnosis efficiency of lung cancer, including
measurement of SHOX2 and RASSF1A gene methylation.
BMC Cancer. 2024;24:282. PubMedAbstract available
February 2024
XU M, Li C, Xiang L, Chen S, et al Assessing the causal relationship between 731 immunophenotypes and the risk of
lung cancer: a bidirectional mendelian randomization study.
BMC Cancer. 2024;24:270. PubMedAbstract available
WANG X, Zhao J, Mei T, Liu W, et al Quantification of preexisting lung ground glass opacities on CT for predicting
checkpoint inhibitor pneumonitis in advanced non-small cell lung cancer patients.
BMC Cancer. 2024;24:269. PubMedAbstract available
CHEN K, Li S, Chen M, Jin Z, et al Endostar acts as a pneumonitis protectant in patients with locally advanced
non-small cell lung cancer receiving concurrent chemoradiotherapy.
BMC Cancer. 2024;24:257. PubMedAbstract available
CHEN HC, Kuo CY, Chang Y, Tsai DL, et al 5-Methoxytryptophan enhances the sensitivity of sorafenib on the inhibition of
proliferation and metastasis for lung cancer cells.
BMC Cancer. 2024;24:248. PubMedAbstract available
LANG Y, Lin Y, Deng M, Liu X, et al Economic evaluation of cemiplimab plus chemotherapy regimen for advanced
non-small-cell lung cancer.
BMC Cancer. 2024;24:236. PubMedAbstract available
CHENG WC, Lin CC, Liao WC, Lin YC, et al The difference between dacomitinib and afatinib in effectiveness and safety in
first-line treatment of patients with advanced EGFR-mutant non-small cell lung
cancer: a real-world observational study.
BMC Cancer. 2024;24:228. PubMedAbstract available
HUANG CY, Hsieh MS, Hsieh PC, Wu YK, et al Pulmonary rehabilitation improves exercise capacity, health-related quality of
life, and cardiopulmonary function in patients with non-small cell lung cancer.
BMC Cancer. 2024;24:211. PubMedAbstract available
THAMRONGJIRAPAT T, Muntham D, Incharoen P, Trachu N, et al Molecular alterations and clinical prognostic factors in resectable non-small
cell lung cancer.
BMC Cancer. 2024;24:200. PubMedAbstract available
YIN H, Jia W, Yu J, Zhu H, et al Radiation pneumonitis after concurrent aumolertinib and thoracic radiotherapy in
EGFR-mutant non-small cell lung cancer patients.
BMC Cancer. 2024;24:197. PubMedAbstract available
FARAMARZI S, Kiani B, Faramarzi S, Firouraghi N, et al Cancer patterns in Iran: a gender-specific spatial modelling of cancer incidence
during 2014-2017.
BMC Cancer. 2024;24:191. PubMedAbstract available
SHIM YB, Oh BC, Lee EK, Park MH, et al Comparison of partitioned survival modeling with state transition modeling
approaches with or without consideration of brain metastasis: a case study of
Osimertinib versus pemetrexed-platinum.
BMC Cancer. 2024;24:189. PubMedAbstract available
WANG Y, Ren H Multi-omics sequencing revealed endostar combined with cisplatin treated non
small cell lung cancer via anti-angiogenesis.
BMC Cancer. 2024;24:187. PubMedAbstract available
ZHAO M, Shao T, Shao H, Zhou C, et al Identifying optimal ALK inhibitors in first- and second-line treatment of
patients with advanced ALK-positive non-small-cell lung cancer: a systematic
review and network meta-analysis.
BMC Cancer. 2024;24:186. PubMedAbstract available
ELSHAMI M, Sawafta N, Mansour A, Alser M, et al Anticipated time to seek medical advice for possible lung cancer symptoms and
barriers to timely presentation in Palestine: a national cross-sectional study.
BMC Cancer. 2024;24:183. PubMedAbstract available
YAN N, Zhang H, Shen S, Guo S, et al Response to immune checkpoint inhibitor combination therapy in metastatic
RET-mutated lung cancer from real-world retrospective data.
BMC Cancer. 2024;24:178. PubMedAbstract available
PHAM CP, Nguyen TTH, Do AT, Nguyen TK, et al A real-world cohort study of first-line afatinib in patients with EGFR-mutant
advanced non-small cell lung cancer in Vietnam.
BMC Cancer. 2024;24:176. PubMedAbstract available
WU J, Zhou Y, Xu C, Yang C, et al Effectiveness of CT radiomic features combined with clinical factors in
predicting prognosis in patients with limited-stage small cell lung cancer.
BMC Cancer. 2024;24:170. PubMedAbstract available
January 2024
SHIN S, Moon J, Oum C, Kim S, et al Discontinuation risk from adverse events: immunotherapy alone vs. combined with
chemotherapy: a systematic review and network meta-analysis.
BMC Cancer. 2024;24:152. PubMedAbstract available
DONG W, Yin Y, Yang S, Liu B, et al Impact of chronic obstructive pulmonary disease on the efficacy and safety of
neoadjuvant immune checkpoint inhibitors combined with chemotherapy for
resectable non-small cell lung cancer: a retrospective cohort study.
BMC Cancer. 2024;24:153. PubMedAbstract available
XUE M, Liu J, Li Z, Lu M, et al The role of adenocarcinoma subtypes and immunohistochemistry in predicting lymph
node metastasis in early invasive lung adenocarcinoma.
BMC Cancer. 2024;24:139. PubMedAbstract available
LIU JS, Cai YX, He YZ, Xu J, et al Spatial and temporal heterogeneity of tumor immune microenvironment between
primary tumor and brain metastases in NSCLC.
BMC Cancer. 2024;24:123. PubMedAbstract available
ZHANG Y, Zhang C, He M, Xing W, et al Co-expression of IL-21-Enhanced NKG2D CAR-NK cell therapy for lung cancer.
BMC Cancer. 2024;24:119. PubMedAbstract available
QIAN J, He Z, Wu Y, Li H, et al Analysis of the efficacy of upfront brain radiotherapy versus deferred
radiotherapy for EGFR/ALK-positive non-small cell lung cancer with brain
metastases: a retrospective study.
BMC Cancer. 2024;24:117. PubMedAbstract available
LI R, Liang H, Li J, Shao Z, et al Paclitaxel liposome (Lipusu) based chemotherapy combined with immunotherapy for
advanced non-small cell lung cancer: a multicenter, retrospective real-world
study.
BMC Cancer. 2024;24:107. PubMedAbstract available
JIA QC, Qin L, Niu Y, Liu L, et al Red blood cell distribution width is associated with sarcopenia risk in
early-stage non-small cell lung cancer.
BMC Cancer. 2024;24:95. PubMedAbstract available
QIN B, Xin L, Liang C, Li L, et al Efficacy and safety of anti-PD-1 inhibitor versus anti-PD-L1 inhibitor in
first-line treatment of extensive-stage small cell lung cancer: a multicenter
retrospective study.
BMC Cancer. 2024;24:100. PubMedAbstract available
LIU W, Du Q, Mei T, Wang J, et al Comprehensive analysis the prognostic and immune characteristics of mitochondrial
transport-related gene SFXN1 in lung adenocarcinoma.
BMC Cancer. 2024;24:94. PubMedAbstract available
LI J, Li L, Tang S, Yu Q, et al Novel model integrating computed tomography-based image markers with genetic
markers for discriminating radiation pneumonitis in patients with unresectable
stage III non-small cell lung cancer receiving radiotherapy: a retrospective
multi-center radio
BMC Cancer. 2024;24:78. PubMedAbstract available
ZHAO Z, Gu S, Yang Y, Wu W, et al A cost-effectiveness analysis of lung cancer screening with low-dose computed
tomography and a polygenic risk score.
BMC Cancer. 2024;24:73. PubMedAbstract available
YANO Y, Abnet CC, Roshandel G, Graf A, et al Dental health and lung cancer risk in the Golestan Cohort Study.
BMC Cancer. 2024;24:74. PubMedAbstract available
KIM TH, Choi JH, Ahn MS, Lee HW, et al Differential efficacy of tyrosine kinase inhibitors according to the types of
EGFR mutations and agents in non-small cell lung cancer: a real-world study.
BMC Cancer. 2024;24:70. PubMedAbstract available
CHEN C, Liu H, Li Y, Xu Q, et al Downregulation of PTPRT elevates the expression of survivin and promotes the
proliferation, migration, and invasion of lung adenocarcinoma.
BMC Cancer. 2024;24:63. PubMedAbstract available
LIU B, Feng Y, Xie N, Yang Y, et al FERMT1 promotes cell migration and invasion in non-small cell lung cancer via
regulating PKP3-mediated activation of p38 MAPK signaling.
BMC Cancer. 2024;24:58. PubMedAbstract available
YAN M, Kang W, Liu X, Yang B, et al Prognostic value of plasma microRNAs for non-small cell lung cancer based on data
mining models.
BMC Cancer. 2024;24:52. PubMedAbstract available
LU Y, He W, Huang X, Xiao X, et al Pulsatilla saponin D regulates ras-related C3 botulinum toxin substrate 3 (RAC3)
to overcome resistance to paclitaxel in lung adenocarcinoma cells.
BMC Cancer. 2024;24:55. PubMedAbstract available
AI F, Zhao J, Yang W, Wan X, et al Estimating smoking-attributable lung cancer mortality in Chinese adults from 2000
to 2020: a comparison of three methods.
BMC Cancer. 2024;24:47. PubMedAbstract available
CHEN LD, Lin L, Chen JZ, Song Y, et al Identification of key genes in chronic intermittent hypoxia-induced lung cancer
progression based on transcriptome sequencing.
BMC Cancer. 2024;24:41. PubMedAbstract available
GUO M, Cao Z, Huang Z, Hu S, et al The value of CT shape quantification in predicting pathological classification of
lung adenocarcinoma.
BMC Cancer. 2024;24:35. PubMedAbstract available
LIU Y, Han T, Miao R, Zhou J, et al RACGAP1 promotes the progression and poor prognosis of lung adenocarcinoma
through its effects on the cell cycle and tumor stemness.
BMC Cancer. 2024;24:7. PubMedAbstract available
ZHAO S, Miao M, Wang Q, Zhao H, et al The current status of clinical trials on cancer and age disparities among the
most common cancer trial participants.
BMC Cancer. 2024;24:30. PubMedAbstract available
WANG XC, Zhang L, Lin JB, Huang XY, et al Imaging diagnosis and differential diagnosis of extraskeletal osteosarcoma.
BMC Cancer. 2024;24:11. PubMedAbstract available
ZHOU F, Wang M, Wang Z, Li W, et al Screening of novel tumor-associated antigens for lung adenocarcinoma mRNA vaccine
development based on pyroptosis phenotype genes.
BMC Cancer. 2024;24:28. PubMedAbstract available
December 2023
DU C, Chen Y, Zhou Y, Zheng D, et al Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC.
BMC Cancer. 2023;23:1260. PubMedAbstract available
SHEN GY, Huang RZ, Yang SB, Shen RQ, et al High SNHG expression may predict a poor lung cancer prognosis based on a
meta-analysis.
BMC Cancer. 2023;23:1243. PubMedAbstract available
ZHENG X, Zhang L, Wu L, Zhao J, et al Baseline C-reactive protein predicts efficacy of the first-line immune checkpoint
inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: a
retrospective, multicenter study.
BMC Cancer. 2023;23:1244. PubMedAbstract available
ZHANG K, Zhang T, Guo Z, Zhao F, et al Adding simultaneous integrated boost to whole brain radiation therapy improved
intracranial tumour control and minimize radiation-induced brain injury risk for
the treatment of brain metastases.
BMC Cancer. 2023;23:1240. PubMedAbstract available
VOLPE S, Zaffaroni M, Piperno G, Vincini MG, et al Multi-omics integrative modelling for stereotactic body radiotherapy in
early-stage non-small cell lung cancer: clinical trial protocol of the MONDRIAN
study.
BMC Cancer. 2023;23:1236. PubMedAbstract available
ARIMURA K, Hiroshima K, Nagashima Y, Nakazawa T, et al LAG3 is an independent prognostic biomarker and potential target for immune
checkpoint inhibitors in malignant pleural mesothelioma: a retrospective study.
BMC Cancer. 2023;23:1206. PubMedAbstract available
WANG Y, Li L, Hu J, Zhao Y, et al Comparison of efficacy and safety between PD-1 inhibitors and PD-L1 inhibitors
plus platinum-etoposide as first-line treatment for extensive-stage small-cell
lung cancer: a multicenter, real-world analysis.
BMC Cancer. 2023;23:1196. PubMedAbstract available
SONG Z, Ma H, Sun H, Li Q, et al Construction and validation of a nomogram to predict the overall survival of
small cell lung cancer: a multicenter retrospective study in Shandong province,
China.
BMC Cancer. 2023;23:1182. PubMedAbstract available
November 2023
ZHENG Q, Wang T, Jiang G, Li M, et al Immunoglobulin superfamily 6 is a molecule involved in the anti-tumor activity of
macrophages in lung adenocarcinoma.
BMC Cancer. 2023;23:1170. PubMedAbstract available
MILLS S, Donnan P, Buchanan D, Smith BH, et al Age and cancer type: associations with increased odds of receiving a late
diagnosis in people with advanced cancer.
BMC Cancer. 2023;23:1174. PubMedAbstract available
DE MORAES FCA, Pasqualotto E, Lopes LM, Cavalcanti Souza ME, et al PD-1/PD-L1 inhibitors plus carboplatin and paclitaxel compared with carboplatin
and paclitaxel in primary advanced or recurrent endometrial cancer: a systematic
review and meta-analysis of randomized clinical trials.
BMC Cancer. 2023;23:1166. PubMedAbstract available
LIU ZT, Shen JT, Lei YJ, Huang YC, et al Molecular subtyping based on immune cell marker genes predicts prognosis and
therapeutic response in patients with lung adenocarcinoma.
BMC Cancer. 2023;23:1141. PubMedAbstract available
JIN S, Liu T, Wang W, Li T, et al Lymphocyte migration regulation related proteins in urine exosomes may serve as a
potential biomarker for lung cancer diagnosis.
BMC Cancer. 2023;23:1125. PubMedAbstract available
LI S, Wang W, Yu H, Zhang S, et al Characterization of genomic instability-related genes predicts survival and
therapeutic response in lung adenocarcinoma.
BMC Cancer. 2023;23:1115. PubMedAbstract available
SAMEJIMA H, Kojima K, Fujiwara A, Tokunaga T, et al The combination of PD-L1 expression and the neutrophil-to-lymphocyte ratio as a
prognostic factor of postoperative recurrence in non-small-cell lung cancer: a
retrospective cohort study.
BMC Cancer. 2023;23:1107. PubMedAbstract available
SUN J, Hu JR, Liu CF, Li Y, et al ANKRD49 promotes the metastasis of NSCLC via activating JNK-ATF2/c-Jun-MMP-2/9
axis.
BMC Cancer. 2023;23:1108. PubMedAbstract available
MISAWA S, Denda T, Kodama S, Suzuki T, et al Efficacy and safety of mirogabalin for chemotherapy-induced peripheral
neuropathy: a prospective single-arm trial (MiroCIP study).
BMC Cancer. 2023;23:1098. PubMedAbstract available
HONG W, Zhang T, Shan C, Li H, et al Stroke as initial manifestation of non-small cell lung cancer with Trousseau
syndrome.
BMC Cancer. 2023;23:1096. PubMedAbstract available
LOCOCO F, Boldrini L, Diepriye CD, Evangelista J, et al Correction: Lung cancer multi-omics digital human avatars for integrating
precision medicine into clinical practice: the LANTERN study.
BMC Cancer. 2023;23:1082. PubMed
ROUSSOT N, Fumet JD, Limagne E, Thibaudin M, et al A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic
body radiation therapy in patients with metastatic multiorgan cancer.
BMC Cancer. 2023;23:1080. PubMedAbstract available
CHE K, Hong C, He Y, Peng D, et al Association of immune-related adverse events with COVID-19 pneumonia in lung
cancer patients receiving immune checkpoint inhibitors: a cross-sectional study
in China.
BMC Cancer. 2023;23:1069. PubMedAbstract available
ISAKA T, Adachi H, Murakami K, Miura J, et al Preoperative predictors for recurrence sites associated with poor post-recurrence
survival after surgery of non-small cell lung cancer: a multicenter study.
BMC Cancer. 2023;23:1064. PubMedAbstract available
October 2023
WANG Y, Yu T, Chen J, Zhao R, et al Immune characteristics analysis and construction of a four-gene prognostic
signature for lung adenocarcinoma based on estrogen reactivity.
BMC Cancer. 2023;23:1047. PubMedAbstract available
SONG Y, Lin S, Chen J, Dang J, et al First-line treatment with TKI plus brain radiotherapy versus TKI alone in
EGFR-mutated non-small cell Lung cancer with brain metastases: a systematic
review and meta-analysis.
BMC Cancer. 2023;23:1043. PubMedAbstract available
AFTAB R, Qiang Y, Zhao J, Urrehman Z, et al Graph Neural Network for representation learning of lung cancer.
BMC Cancer. 2023;23:1037. PubMedAbstract available
ZHANG T, Li S, Chang J, Qin Y, et al Impact of BMI on the survival outcomes of non-small cell lung cancer patients
treated with immune checkpoint inhibitors: a meta-analysis.
BMC Cancer. 2023;23:1023. PubMedAbstract available
TAFENZI HA, Choulli F, Adjade G, Baladi A, et al Development of a well-defined tool to predict the overall survival in lung cancer
patients: an African based cohort.
BMC Cancer. 2023;23:1016. PubMedAbstract available
NAGASAKA M, Zhang SS, Baca Y, Xiu J, et al Pan-tumor survey of ROS1 fusions detected by next-generation RNA and whole
transcriptome sequencing.
BMC Cancer. 2023;23:1000. PubMedAbstract available
KIM H, Hwang J, Kim SM, Choi J, et al Risk factor analysis of the development of severe radiation pneumonitis in
patients with non-small cell lung cancer treated with curative radiotherapy, with
focus on underlying pulmonary disease.
BMC Cancer. 2023;23:992. PubMedAbstract available
PU X, Zhou Y, Kong Y, Chen B, et al Efficacy and safety of dacomitinib in treatment-naive patients with advanced
NSCLC harboring uncommon EGFR mutation: an ambispective cohort study.
BMC Cancer. 2023;23:982. PubMedAbstract available
ZHAO C, Tong L, Liu B, Qi F, et al Plasma hepatocyte growth factor as a noninvasive biomarker in small cell lung
cancer.
BMC Cancer. 2023;23:973. PubMedAbstract available
YANG Z, Zhong W, Luo Y, Wu C, et al The timing of durvalumab administration affects the risk of pneumonitis in
patients with locally advanced non-small cell lung cancer: a systematic review
and meta-analysis.
BMC Cancer. 2023;23:962. PubMedAbstract available
GAO Y, Wang X, Zhao X, Zhu C, et al Multiphase CT radiomics nomogram for preoperatively predicting the WHO/ISUP
nuclear grade of small (< 4 cm) clear cell renal cell carcinoma.
BMC Cancer. 2023;23:953. PubMedAbstract available
CHEN Y, Gong L, Gu P, Hua Y, et al Pan-immune-inflammation and its dynamics: predictors of survival and
immune-related adverse events in patients with advanced NSCLC receiving
immunotherapy.
BMC Cancer. 2023;23:944. PubMedAbstract available
WANG W, Wang S, Wang M, Ma Y, et al Effects of TRAF3 on the proliferation and migration of lung adenocarcinoma depend
partly on pyroptosis.
BMC Cancer. 2023;23:942. PubMedAbstract available
ZHAO Z, Sun Y, Tang J, Yang Y, et al LRPPRC regulates malignant behaviors, protects mitochondrial homeostasis,
mitochondrial function in osteosarcoma and derived cancer stem-like cells.
BMC Cancer. 2023;23:935. PubMedAbstract available
ZHANG Y, Qu H, Tian Y, Na F, et al PB-LNet: a model for predicting pathological subtypes of pulmonary nodules on CT
images.
BMC Cancer. 2023;23:936. PubMedAbstract available
WANG Y, Pan J, An F, Chen K, et al GBP2 is a prognostic biomarker and associated with immunotherapeutic responses in
gastric cancer.
BMC Cancer. 2023;23:925. PubMedAbstract available
AMIN A, Koul AM, Wani UM, Farooq F, et al Dissection of paracrine/autocrine interplay in lung tumor microenvironment
mimicking cancer cell-monocyte co-culture models reveals proteins that promote
inflammation and metastasis.
BMC Cancer. 2023;23:926. PubMedAbstract available
September 2023
SHAO CY, Luo J, Ju S, Li CL, et al Online decision tools for personalized survival prediction and treatment
optimization in elderly patients with lung squamous cell carcinoma: a
retrospective cohort study.
BMC Cancer. 2023;23:920. PubMedAbstract available
LI X, An W, Pan H, Fan Y, et al Correction: Wilms' tumour gene 1 (WT1) enhances non-small cell lung cancer
malignancy and is inhibited by microRNA-498-5p.
BMC Cancer. 2023;23:909. PubMed
WAKUDA K, Kenmotsu H, Sato Y, Nakamura A, et al Randomized, open-label phase II study of brigatinib and carboplatin plus
pemetrexed and brigatinib alone for chemotherapy-naive patients with
ALK-rearranged non-squamous non-small cell lung cancer: treatment rationale and
protocol design of the B-DASH
BMC Cancer. 2023;23:902. PubMedAbstract available
REN Q, Li Q, Shao C, Zhang P, et al Establishing a prognostic model based on immune-related genes and identification
of BIRC5 as a potential biomarker for lung adenocarcinoma patients.
BMC Cancer. 2023;23:897. PubMedAbstract available
ALIMBETOV D, Umbayev B, Tsoy A, Begimbetova D, et al Small molecule targeting of the p38/Mk2 stress signaling pathways to improve
cancer treatment.
BMC Cancer. 2023;23:895. PubMedAbstract available
ZHOU T, Wang Z, Qiao C, Wang S, et al Sleep disturbances and the risk of lung cancer: a meta-epidemiological study.
BMC Cancer. 2023;23:884. PubMedAbstract available
LIAO Z, Zheng R, Li N, Shao G, et al Development and validation of a risk model with variables related to non-small
cell lung cancer in patients with pulmonary nodules: a retrospective study.
BMC Cancer. 2023;23:872. PubMedAbstract available
BHAT GR, Jamwal RS, Sethi I, Bhat A, et al Associations between telomere attrition, genetic variants in telomere maintenance
genes, and non-small cell lung cancer risk in the Jammu and Kashmir population of
North India.
BMC Cancer. 2023;23:874. PubMedAbstract available
SIMIENE J, Dabkeviciene D, Stanciute D, Prokarenkaite R, et al Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC.
BMC Cancer. 2023;23:857. PubMedAbstract available
CHEN CL, Wang ST, Liao WC, Chen CH, et al A real-world study comparing perioperative chemotherapy and EGFR-tyrosine kinase
inhibitors for treatment of resected stage III EGFR-mutant adenocarcinoma.
BMC Cancer. 2023;23:847. PubMedAbstract available
SON SM, Yun J, Kim DW, Jung YS, et al MicroRNA 29a therapy for CEACAM6-expressing lung adenocarcinoma.
BMC Cancer. 2023;23:843. PubMedAbstract available
KANAOKA K, Sumikawa H, Oyamada S, Tamiya A, et al Osteoblastic bone reaction in non-small cell lung cancer harboring epidermal
growth factor receptor mutation treated with osimertinib.
BMC Cancer. 2023;23:834. PubMedAbstract available
ROH J, Kim B, Im M, Jang W, et al MALAT1-regulated gene expression profiling in lung cancer cell lines.
BMC Cancer. 2023;23:818. PubMedAbstract available
CHENG G, Wu J, Ji M, Hu W, et al TET2 inhibits the proliferation and metastasis of lung adenocarcinoma cells via
activation of the cGAS-STING signalling pathway.
BMC Cancer. 2023;23:825. PubMedAbstract available
LI X, An W, Pan H, Fan Y, et al Wilms' tumour gene 1 (WT1) enhances non-small cell lung cancer malignancy and is
inhibited by microRNA-498-5p.
BMC Cancer. 2023;23:824. PubMedAbstract available
CAI JS, Yang F, Wang X Occult lymph node metastasis is not a favorable factor for resected NSCLC
patients.
BMC Cancer. 2023;23:822. PubMedAbstract available